var title_f24_50_25376="Pemphigoid gestationis abd";
var content_f24_50_25376=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F63947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F63947&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pemphigoid gestationis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scattered erythematous, urticarial plaques are present on the abdomen of this patient with pemphigoid gestationis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25376=[""].join("\n");
var outline_f24_50_25376=null;
var title_f24_50_25377="Brown tumors of pelvic bones findings on CT";
var content_f24_50_25377=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87016&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Brown tumors of pelvic bones: Findings on computerized tomography (CT)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The CT scan of pelvis shows multiple lytic lesions in the pelvis (white arrows) consistent with brown tumors.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25377=[""].join("\n");
var outline_f24_50_25377=null;
var title_f24_50_25378="Patient information: Creutzfeldt-Jakob disease (The Basics)";
var content_f24_50_25378=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83084\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/57/39824\">",
"         EEG (electroencephalogram)",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?24/61/25554\">",
"         Patient information: Advance directives (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/14/31970\">",
"         Patient information: Dementia (including Alzheimer disease) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/0/18434\">",
"         Patient information: EEG (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/3/31793\">",
"         Patient information: Evaluating memory and thinking problems (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/21/25939\">",
"         Patient information: Medical care during advanced illness (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?14/37/14934\">",
"         Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Creutzfeldt-Jakob disease (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/creutzfeldt-jakob-disease-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H18071765\">",
"      <span class=\"h1\">",
"       What is Creutzfeldt-Jakob disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Creutzfeldt-Jakob disease, or &ldquo;CJD,&rdquo; is a rare brain disorder that causes muscle twitching and dementia. Dementia is the general term for a group of brain disorders that cause memory and thinking problems. CJD gets worse quickly and leads to death within several months of when the symptoms first start.",
"     </p>",
"     <p>",
"      CJD happens most often in older adults. It is caused by abnormal proteins called &ldquo;prions&rdquo; that infect the brain.",
"     </p>",
"     <p>",
"      There are different types of CJD. The more common type is called &ldquo;classic&rdquo; CJD. In rare cases, people have gotten classic CJD after they had transplant surgery and got an infected organ. But in most cases, doctors don&rsquo;t know how people get classic CJD. Doctors do know, however, that the disease is not spread by sneezing, coughing, or touching.",
"     </p>",
"     <p>",
"      An even less common type of CJD, called &ldquo;variant&rdquo; CJD, can happen after people eat beef that is infected with the disease. (This is sometimes known as &ldquo;mad cow disease.&rdquo;) But thanks to new government rules, variant CJD almost never happens anymore.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18071780\">",
"      <span class=\"h1\">",
"       What are the symptoms of Creutzfeldt-Jakob disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The 2 most common symptoms of CJD are:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Dementia, which is the word doctors use for trouble with concentration, memory, or thinking",
"       </li>",
"       <li>",
"        Muscle twitches or jerks, which doctors call &ldquo;myoclonus&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People with CJD also usually have other symptoms that can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Behavior changes",
"       </li>",
"       <li>",
"        Mood changes, such as depression",
"       </li>",
"       <li>",
"        Trouble walking or problems with balance",
"       </li>",
"       <li>",
"        Sleeping much more or much less than usual",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      These symptoms are similar to those that happen with other, more common types of dementia, such as Alzheimer disease. But in CJD, the symptoms get worse much faster than in Alzheimer disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18071795\">",
"      <span class=\"h1\">",
"       Is there a test for Creutzfeldt-Jakob disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Doctors usually do tests to make sure a person has CJD and not another condition. These tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An MRI of the brain &ndash; This is an imaging test that creates pictures of the brain.",
"       </li>",
"       <li>",
"        An EEG (or &ldquo;electroencephalogram&rdquo;) &ndash; An EEG is a test that measures electrical activity in the brain and records brain wave patterns (",
"        <a class=\"graphic graphic_figure graphicRef55691 \" href=\"UTD.htm?38/57/39824\">",
"         figure 1",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        A lumbar puncture (sometimes called a &ldquo;spinal tap&rdquo;) &ndash; During this procedure, the doctor puts a thin needle into the lower back and removes a small amount of spinal fluid. Spinal fluid is the fluid that surrounds the brain and spinal cord. He or she will send the spinal fluid to a lab for tests.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Doctors can usually tell if someone has CJD from the results of these tests. But the only test that can show for sure if someone has CJD is a brain biopsy. For a biopsy, a doctor removes a sample of brain tissue. Then another doctor looks at the tissue under a microscope. Most people do not need to have a brain biopsy.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18071810\">",
"      <span class=\"h1\">",
"       How is Creutzfeldt-Jakob disease treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Sadly, there are no treatments that can stop or cure the disease. The dementia keeps getting worse, and all people with CJD die within several months after their symptoms start.",
"     </p>",
"     <p>",
"      If needed, doctors sometimes prescribe medicines to help calm down a person&rsquo;s behavior or to help with the muscle jerks.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18071825\">",
"      <span class=\"h1\">",
"       What if my family member has Creutzfeldt-Jakob disease?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your family member has CJD, you need to make plans for the future. You need to make plans for his or her:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Living situation &ndash; If your family member lives alone, you need to make sure he or she is safe. When he or she can&rsquo;t live alone, you need to decide whether he or she will live at home with help, or move to a nursing home.",
"       </li>",
"       <li>",
"        Decision-making &ndash; Early on, your family member should choose a &ldquo;power of attorney.&rdquo; A power of attorney is someone who can make decisions (including medical decisions) for him or her when he or she is no longer able to.",
"       </li>",
"       <li>",
"        Money &ndash; As the disease gets worse, your family member will be unable to manage his or her money.",
"       </li>",
"       <li>",
"        Driving &ndash; If your family member still drives, talk with the doctor about when he or she should stop.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H18071840\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=see_link\">",
"       Patient information: Dementia (including Alzheimer disease) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/3/31793?source=see_link\">",
"       Patient information: Evaluating memory and thinking problems (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/0/18434?source=see_link\">",
"       Patient information: EEG (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/61/25554?source=see_link\">",
"       Patient information: Advance directives (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=see_link\">",
"       Patient information: Medical care during advanced illness (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=see_link\">",
"       Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/50/25378?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83084 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-DE283444F4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25378=[""].join("\n");
var outline_f24_50_25378=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18071765\">",
"      What is Creutzfeldt-Jakob disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18071780\">",
"      What are the symptoms of Creutzfeldt-Jakob disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18071795\">",
"      Is there a test for Creutzfeldt-Jakob disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18071810\">",
"      How is Creutzfeldt-Jakob disease treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18071825\">",
"      What if my family member has Creutzfeldt-Jakob disease?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18071840\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83084\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/57/39824\">",
"      EEG (electroencephalogram)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/61/25554?source=related_link\">",
"      Patient information: Advance directives (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/0/18434?source=related_link\">",
"      Patient information: EEG (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/3/31793?source=related_link\">",
"      Patient information: Evaluating memory and thinking problems (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/21/25939?source=related_link\">",
"      Patient information: Medical care during advanced illness (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_50_25379="Vulvar anatomy";
var content_f24_50_25379=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Anatomy of the vulva",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 499px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25379=[""].join("\n");
var outline_f24_50_25379=null;
var title_f24_50_25380="Anterior wall MI four chamber echo 1";
var content_f24_50_25380=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/70619/4chanmi1_conv.mp4?title=Anterior+wall+MI+four+chamber+echo+1\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior wall myocardial infarction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 250px; height: 424px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Four chamber view from a 2-D echocardiogram shows a hypokinetic and akinetic anterior wall and apex of the left ventricle. The base of the left ventricle contracts normally and the interventricular septum in this area has normal thickening in systole.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25380=[""].join("\n");
var outline_f24_50_25380=null;
var title_f24_50_25381="Burn class depth skin";
var content_f24_50_25381=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F73309&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F73309&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Burn classification",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 421px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25381=[""].join("\n");
var outline_f24_50_25381=null;
var title_f24_50_25382="Gastrogastric fistula after gastric bypass";
var content_f24_50_25382=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F73814&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F73814&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 492px\">",
"   <div class=\"ttl\">",
"    Gastrogastric fistula after gastric bypass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 472px; height: 577px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Arrow points to the gastrogastric fistula after gastric bypass, originating at the gastrojejunostomy.",
"    <br>",
"     (B) Arrows point to gastric pouch with contrast and air and the gastric remnant with air, indicative of a gastrogastric fistula.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25382=[""].join("\n");
var outline_f24_50_25382=null;
var title_f24_50_25383="Morphea - histopathology";
var content_f24_50_25383=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F76952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F76952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Morphea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 323px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Thick collagen bundles and a sparse interstitial and perivascular inflammatory infiltrate are present in the dermis. Adnexal structures are absent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25383=[""].join("\n");
var outline_f24_50_25383=null;
var title_f24_50_25384="Evaluation and diagnosis of bladder dysfunction in children";
var content_f24_50_25384=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation and diagnosis of bladder dysfunction in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Kenneth G Nepple, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Christopher S Cooper, MD, FACS, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Laurence S Baskin, MD, FAAP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25384/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/50/25384/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder dysfunction, also referred to as voiding dysfunction, is a general term to describe abnormalities in either the filling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emptying of the bladder. It is a common problem in children and constitutes up to 40 percent of pediatric urology clinic visits [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/1\">",
"     1",
"    </a>",
"    ]. In some children, bladder dysfunction is a component of bowel and bladder dysfunction, previously been referred to as dysfunction elimination, which involves abnormalities in both bladder and bowel emptying.",
"   </p>",
"   <p>",
"    Daytime urinary incontinence, a common feature of bladder dysfunction, can cause major stress in school-age children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], and negatively impact upon a child's self-esteem [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, it is desirable to identify and treat affected school-age children as early as possible.",
"   </p>",
"   <p>",
"    The evaluation of non-neurologic bladder dysfunction in children will be reviewed here. The etiology and clinical features of bladder dysfunction in children are discussed separately. The clinical features, evaluation, and management of children with bladder dysfunction due to myelomeningocele also are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=see_link\">",
"     \"Management of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=see_link\">",
"     \"Urinary tract complications of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of the evaluation for suspected bladder dysfunction in children are to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Determine whether the child has an abnormality in either filling or emptying the bladder.",
"     </li>",
"     <li>",
"      If there is a bladder function abnormality, the evaluation should determine the underlying cause. Specifically, the assessment should distinguish organic (ie, neurogenic or anatomical) from functional causes of bladder dysfunction because management differs depending upon the etiology. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H4#H4\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Etiology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evaluation for most children with bladder dysfunction can be limited to a thorough history, physical examination, and noninvasive testing, such as a urinalysis and urine culture. In selected children, more extensive evaluation including urologic imaging studies, measurements of urinary flow, and urodynamic studies may be required to diagnose the underlying problem and determine the most appropriate therapeutic approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     WHEN TO SUSPECT BLADDER DYSFUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder dysfunction should be considered in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Daytime urinary incontinence in school-age or previously toilet-trained children.",
"     </li>",
"     <li>",
"      Persistent urinary symptoms such as urgency, dribbling, or pain during urination (see",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Bladder dysfunction has been associated with conditions such as vesicoureteral reflux, recurrent urinary infections, and chronic constipation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation for suspected bladder dysfunction in a child includes a thorough history, focused physical examination, and minimal laboratory testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough history is important in determining whether bladder dysfunction is present and, if so, may identify the underlying cause. The history should be tailored to the age of the patient and the appropriate stage in their development of bladder control. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H3#H3\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Normal voiding'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The history should seek information about the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Voiding schedule &ndash; Voiding schedule includes the frequency of voids and, in toilet-trained children, the frequency of incontinent episodes. If possible, an estimation of the voided volume should also be obtained. Large voids may indicate a large capacity bladder seen in children with underactive bladders or polyuria.",
"     </li>",
"     <li>",
"      Symptoms of bladder dysfunction &ndash; Bladder dysfunctional symptoms include urgency, pain during urination, holding maneuvers, hesitancy, dribbling, straining, and an intermittent or weak urinary stream. The definitions for these symptoms are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H2#H2\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Definitions of symptoms'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Dysfunctional Voiding Symptom Survey is a questionnaire, used in some pediatric urologic centers, consisting of 10 questions that assess daytime incontinence, constipation, urgency, voiding frequency, and dysuria [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/1\">",
"     1",
"    </a>",
"    ]. A scoring system based upon a scale of 0 to 3 for each question results in an overall score indicative of the severity of bladder dysfunction.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bowel habits &ndash; Because constipation is often seen in children with bladder dysfunction, information regarding the child's bowel habits should be obtained. This includes the frequency of bowel movements, the consistency of stool, and any history of fecal soiling. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H17#H17\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Constipation and dysfunctional elimination syndrome'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Family history &ndash; A family history should screen for any renal or urologic disorders including bladder dysfunction. It is also useful to obtain the age that other family members achieved urinary continence to determine whether there is a familial maturational delay in achieving bladder control.",
"     </li>",
"     <li>",
"      Perinatal and neonatal history &ndash; Screening for any evidence of any perinatal or neonatal insult should be included. As examples, perinatal anoxia or congenital infection could alter the central and peripheral nervous system normal coordination of bladder function, resulting in bladder dysfunction.",
"     </li>",
"     <li>",
"      Diet intake &ndash; The amount and type of fluid should be determined. Excessive fluid intake",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      fluid intake during the night time may be reflective of polyuria due to a concentrating defect, diabetes mellitus, or, less often, primary polydipsia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=see_link\">",
"       \"Diagnosis of polyuria and diabetes insipidus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Previous urinary tract infection &ndash; Urinary tract infection (UTI) and vesicoureteral reflux (VUR) are often seen in children with bladder dysfunction. The management of VUR is more difficult in children with bladder dysfunction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H15#H15\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Urinary tract infection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H16#H16\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Vesicoureteral reflux'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neurodevelopment delay &ndash; Children who are developmentally delayed may also be delayed in gaining voluntary bladder control. Although most children with bladder dysfunction do not have behavior problems [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/5\">",
"       5",
"      </a>",
"      ], there appears to be an increased risk of bladder dysfunction in children with attention deficit hyperactivity disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H18#H18\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Behavioral and neurodevelopmental issues'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Family/parent",
"      </span>",
"      conflict or stress &ndash; Functional causes of bladder dysfunction are often believed to originate from behavioral issues arising from toilet training or personal stress. Voluntary holding with postponement of voiding may be reflective of a conflict between the parent and child [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Toilet training history &ndash; The history should include whether toilet training was prolonged, delayed, or stressful, and whether there was a period of dryness after toilet training. As noted above, a stressful or prolonged history of toilet training may be indicative of",
"      <span class=\"nowrap\">",
"       parental/child",
"      </span>",
"      conflict. Anatomic causes of incontinency, such as an ectopic ureter, will typically have no period of complete dryness after toilet training",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Voiding diary",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of a three-day voiding diary is helpful to obtain an objective record of bowel and urinary voiding patterns. It should include the time and volume of each void, the time of each incontinent episode, fluid intake, the time of each bowel movement, and any episode of fecal soiling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination is focused on detecting neurologic or urologic abnormalities and includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lower back &ndash; The back is examined for cutaneous signs of occult spinal dysraphism or sacral agenesis, such as a presacral dimple, hair patch, lipoma, or asymmetric gluteal cleft.",
"     </li>",
"     <li>",
"      Neurologic examination &ndash; A focused neurologic examination should include assessing lower extremity strength and deep tendon reflexes, gait, fine-motor coordination, perineal and anal sensation, anal wink (anocutaneous reflex), and rectal tone. Any abnormality of the neurologic examination may be indicative of a neurologic lesion that also affects the function of the bladder, which is coordinated by an integrated neural network involving both the peripheral and central nervous system (",
"      <a class=\"graphic graphic_figure graphicRef65433 \" href=\"UTD.htm?10/55/11125\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      External urological examination &ndash; In boys, the examination includes inspection of the meatus to detect any evidence of meatal stenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/8\">",
"       8",
"      </a>",
"      ]. In girls, examination of the labia and vaginal introitus is performed to detect any evidence of labial adhesions. These findings may be a cause of bladder outlet obstruction. Areas of skin excoriation or redness may be present, which may be a sign of continuous or severe urinary leakage.",
"     </li>",
"     <li>",
"      Rectal examination &ndash; Constipation is often an associated comorbidity with bladder dysfunction. In a child with constipation, the digital rectal examination reveals a distended rectum that is full of stool. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15354?source=see_link\">",
"       \"Constipation in children: Etiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Observation of the urine stream &ndash; If possible, direct observation of the urinary stream during voiding should be performed. It allows the clinician to determine whether there is any evidence of hesitancy, dribbling, intermittency of voiding, or weak stream, which are all signs of bladder dysfunction.",
"     </li>",
"     <li>",
"      Evidence of sexual or physical abuse &ndash; The physical examination should look for signs of physical or sexual abuse because bladder dysfunction can be a presenting sign for child abuse [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link&amp;anchor=H9#H9\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'Physical examination'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Findings on a urinalysis, preferably performed on a first morning void (ie, after a period of fluid restriction), may be suggestive of conditions that present with polyuria. These include a low specific gravity due to a renal concentrating defect or glycosuria due to diabetes mellitus.",
"   </p>",
"   <p>",
"    A urine culture should be obtained because children with bladder dysfunction have an increased risk of UTI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H15#H15\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Urinary tract infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum laboratory studies (eg, creatinine) are typically not part of the initial evaluation because abnormalities in overall renal function are rare in children with a normal urinalysis. If there is an abnormal urinalysis, such as that seen with proteinuria, a serum creatinine is obtained to estimate the glomerular filtration rate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of bladder dysfunction is based upon the presence of one or more of the following voiding symptoms, which are defined elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H2#H2\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Definitions of symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased frequency",
"     </li>",
"     <li>",
"      Urgency",
"     </li>",
"     <li>",
"      Hesitancy",
"     </li>",
"     <li>",
"      Dribbling",
"     </li>",
"     <li>",
"      Use of holding maneuvers to suppress voiding",
"     </li>",
"     <li>",
"      Abnormality of urinary flow including weak or intermittent urinary stream",
"     </li>",
"     <li>",
"      Abdominal straining during voiding",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In children with bladder dysfunction, the underlying cause is often suggested by a constellation of signs and symptoms detected during the initial evaluation.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neurologic causes &ndash; Neurologic lesions are suggested by any abnormality detected on neurologic examination, cutaneous signs of occult spinal dysraphism or sacral agenesis, or a history of",
"      <span class=\"nowrap\">",
"       perinatal/neonatal",
"      </span>",
"      injury. These children require further neurologic evaluation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=see_link\">",
"       \"Urinary tract complications of myelomeningocele (spina bifida)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anatomical causes &ndash; Anatomical causes of bladder dysfunction may be suggested by symptoms of a weak stream, such as in boys with posterior urethral valves, or abnormalities detected by physical examination. Further assessment with imaging of the urological system is required to diagnosis an anatomical etiology.",
"     </li>",
"     <li>",
"      Dysfunctional causes &ndash; Most idiopathic bladder dysfunction with no known neurologic or anatomic cause is suggested by findings from the initial evaluation, and a clinical diagnosis can be made based upon the presenting symptoms and signs. In most cases, behavioral therapeutic interventions aimed at retraining the bladder can be initiated based upon a clinical diagnosis of one of the following forms of bladder dysfunction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H6#H6\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Daytime urinary incontinence'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Overactive bladder &ndash; The hallmark symptom of an overactive bladder is urgency.",
"     </li>",
"     <li>",
"      Voiding postponement &ndash; Children who voluntarily postpone voiding usually have a low voiding frequency rate with large volume voids. These children typically utilize holding maneuvers to suppress voiding.",
"     </li>",
"     <li>",
"      Underactive bladder &ndash; Some children with voiding postponement will develop underactive bladder with poor or absent bladder contraction. These children will demonstrate straining (eg, Valsalva maneuver) to aid in voiding, and have a weak and interrupted urinary stream. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Shape of urine flow curve'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Non-neurogenic dysfunctional voiding &ndash; Children with non-neurogenic dysfunctional voiding are unable to relax the urethral sphincter",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pelvic floor musculature during voiding. These children often have constipation resulting in dysfunctional elimination syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     FURTHER EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further diagnostic evaluation for bladder dysfunction includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Urologic imaging",
"     </li>",
"     <li>",
"      Urinary flow measurements",
"     </li>",
"     <li>",
"      Urodynamic studies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies are generally performed under the direction of an urologist with expertise in evaluating children with bladder dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications for further evaluation include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Suspicion of a neurologic or anatomic etiology.",
"     </li>",
"     <li>",
"      Children with suspected bladder dysfunction who are not responsive to behavioral modification therapy. Further evaluation can confirm or change the clinical diagnosis prior to the initiation of pharmacologic therapy.",
"     </li>",
"     <li>",
"      Constant continuous incontinence, since these children are more likely to have an organic cause such as an ectopic ureter.",
"     </li>",
"     <li>",
"      Urinary tract infection or vesicoureteral reflux",
"     </li>",
"     <li>",
"      Suspected renal damage as indicated by proteinuria or an elevated serum creatinine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;A renal and bladder ultrasound is the most commonly used imaging modality in the assessment of children with bladder dysfunction. An ultrasound is a noninvasive study that should be performed in any child with a suspected neurologic or anatomical lesion, urinary tract infections, or symptoms suggestive of an obstructive process (eg, weak urinary stream).",
"   </p>",
"   <p>",
"    Ultrasonography can provide the following information:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Detection of anatomical abnormalities, such as hydronephrosis due to obstruction or vesicoureteral reflux, a double collecting system with an ectopic ureter, or renal scarring.",
"     </li>",
"     <li>",
"      Detection and measurement of postvoid residual volume. A volume greater than 20 mL upon repeat measurement indicates incomplete bladder emptying [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Incomplete emptying is seen in a number of bladder dysfunction disorders including underactive bladder and dysfunctional voiding.",
"     </li>",
"     <li>",
"      Measurement of bladder wall thickness &ndash; The bladder wall is normally less than 3 mm thick when full or less than 5 mm thick when relatively empty [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/12\">",
"       12",
"      </a>",
"      ]. A thickened bladder wall is suggestive of outlet obstruction due to an anatomical (eg, posterior urethral valves) or functional abnormality (eg, non-neurogenic dysfunctional voiding). However, the most common cause of a thickened bladder wall is an overactive bladder (92 percent of cases in one series) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Voiding cystourethrogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;A voiding cystourethrogram (VCUG) is a contrast study that involves urethral catheterization and evaluates the bladder during both the filling and voiding phases. A VCUG is used primarily to assess for vesicoureteral reflux, but also provides information on bladder shape and capacity, bladder emptying, and the presence of posterior urethral valves. The scout film, a plain film of the abdomen, provides information on bony abnormalities and constipation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A VCUG is not typically used to evaluate bladder dysfunction. However, it is obtained in children with urinary tract infection, or in boys suspected of having posterior urethral valves (ie, thick walled bladder and a weak urinary stream). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=see_link&amp;anchor=H7#H7\">",
"     \"Presentation, diagnosis, and clinical course of vesicoureteral reflux\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any child with evidence of neurologic dysfunction should be evaluated with a lumbosacral magnetic resonance imaging (MRI) to look for occult neurologic lesions.",
"   </p>",
"   <p>",
"    However, a normal physical examination does not completely exclude occult spinal cord disorders. In one study of 81 children with treatment refractory bladder dysfunction and a normal physical examination, 39 percent had pathologic findings on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/15\">",
"     15",
"    </a>",
"    ]. Another study suggested expanding the criteria for spinal cord imaging to include children with impaired bladder sensation or incomplete bladder emptying, because these findings occur more frequently in children with spinal cord abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon these data, we obtain a lumbosacral MRI in patients suspected of having a neurologic abnormality, or those who remain refractory to treatment",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    demonstrate urodynamic findings consistent with a neurologic defect. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Urodynamic testing'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=see_link\">",
"     \"Urinary tract complications of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Urinary flow measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of urinary flow (uroflowmetry) is typically only available in a urologic practice caring for patients with bladder dysfunction. It provides useful information regarding the pattern of urine flow that is often diagnostic of an underlying cause, making it unnecessary to pursue more invasive urodynamic testing. Uroflowmetry provides information regarding the emptying phase of the bladder but not the filling phase.",
"   </p>",
"   <p>",
"    For uroflowmetry testing, children are asked to wait until they feel at least a strong desire to void, and if possible, to wait until they have an urgency to void. A minimum flow volume of 100 mL is required to assess urine flow. The child then voids into a collection device that produces a urinary flow curve, which provides the following information:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Shape of urine flow",
"     </li>",
"     <li>",
"      Voided volume",
"     </li>",
"     <li>",
"      Flow time",
"     </li>",
"     <li>",
"      Maximum flow rate (Qmax)",
"     </li>",
"     <li>",
"      Average flow rate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During voiding, electromyographic activity of the urethral sphincter and pelvic floor musculature can be assessed using pads affixed to the perineum. Sphincter activity should be absent during voiding. The presence of sphincter activity during voiding is indicative of dysfunctional voiding.",
"   </p>",
"   <p>",
"    However, there is poor correlation between urinary flow measurements findings and clinical response to therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. In one retrospective study, biofeedback appeared to improve continence and decrease the frequency of urinary tract infection [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/18\">",
"     18",
"    </a>",
"    ]. Clinical responses to biofeedback did not correlate with changes in urinary flow measurements. Similar poor correlations were reported between urinary flow patterns and the clinical response to anticholinergic treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/17\">",
"     17",
"    </a>",
"    ] or the use of timed voiding [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lack of correlation between uroflowmetry and clinical response likely reflects the fact that the majority of cases with incontinence are due to a failure of the storage function of the bladder and not the emptying function, which is measured by uroflowmetry.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Shape of urine flow curve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The International Children's Continence Society (ICCS), a global multidisciplinary organization of clinicians involved in the care of children with lower urinary tract dysfunction, developed categories for normal and abnormal urine flow patterns that correlate with the underlying causes of daytime urinary incontinence (",
"    <a class=\"graphic graphic_figure graphicRef54238 \" href=\"UTD.htm?34/60/35791\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H6#H6\">",
"     \"Etiology and clinical features of bladder dysfunction in children\", section on 'Daytime urinary incontinence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The normal urine flow curve is smooth and has a parabolic shape.",
"     </li>",
"     <li>",
"      The tower flow curve has a high amplitude and short duration peak. It may be produced by the explosive voiding contraction of an overactive bladder. However, children with an overactive bladder may have a normal appearing parabolic curve because an overactive bladder is primarily an abnormality of the filling phase.",
"     </li>",
"     <li>",
"      A plateau curve with low amplitude may be seen when bladder obstruction is present or the urethral sphincter",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pelvic floor musculature are contracted during voiding (ie, dysfunctional voiding).",
"     </li>",
"     <li>",
"      A staccato curve with fluctuating urine flow of high and low amplitude can be seen in children with dysfunctional voiding.",
"     </li>",
"     <li>",
"      An interrupted curve is a fractionated urinary flow of low amplitude and long duration seen in children with underactive bladder who have either an absent or weak detrusor (bladder) contraction. The peaks of urinary flow correlate with the use of abdominal straining (ie, Valsalva maneuver) to empty the bladder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Other parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uroflowmetry provides quantitative information on voided volume, maximum flow rate (Qmax), and average flow rate. The minimum acceptable urine flow rates are 10",
"    <span class=\"nowrap\">",
"     mL/sec",
"    </span>",
"    in boys and 15",
"    <span class=\"nowrap\">",
"     mL/sec",
"    </span>",
"    in girls [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Total bladder capacity is calculated as the sum of the voided volume and the postvoid residual (determined by ultrasonography). The calculated bladder capacity is compared to the expected bladder capacity (EBC). The EBC is based upon the age of the patient and can be calculated as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/21\">",
"     21",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; EBC (mL) &nbsp;= &nbsp;(age of the patient in years + 2) &nbsp;x &nbsp;(30 mL)",
"   </p>",
"   <p>",
"    Some experts use a variation of this formula for children less than two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;EBC (mL) &nbsp;= &nbsp;([2 &nbsp;x &nbsp;age in years] &nbsp;+ &nbsp;2) &nbsp;x &nbsp;(30 mL)",
"   </p>",
"   <p>",
"    Bladder capacity may be diminished in children with overactive bladders. In one study, for example, children with an overactive bladder had a bladder capacity that was 57 percent of the EBC for age [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/22\">",
"     22",
"    </a>",
"    ]. In contrast, children with underactive bladder have increased bladder capacity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Urodynamic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoro-urodynamic testing is a specialized invasive study that involves placement of urethral and rectal catheters to study the bladder during filling and voiding in an awake child. Information obtained includes evaluation of detrusor instability, incontinence, compliance, bladder pressure, bladder capacity, urine flow rate, sphincter activity, and bladder emptying. The bladder is filled with contrast during a urodynamic test, allowing radiographic visualization.",
"   </p>",
"   <p>",
"    Urodynamic testing detects abnormalities both during the filling and voiding phase and is thought to be useful in separating the more common disorder of overactive bladder (filling phase abnormality) from those of dysfunctional voiding due to abnormal sphincter or pelvic musculature contraction during voiding. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Urodynamic patterns'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In a retrospective study of 89 children with bladder dysfunction without a neurologic lesion who had failed conservative therapy, 63 percent had an abnormal urodynamic study, which was twice as likely to be due to a filling rather than a voiding abnormality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, a prospective multicenter study reported a poor correlation between symptoms and urodynamic testing in children with incontinence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/24\">",
"     24",
"    </a>",
"    ]. In this study, during urodynamic testing, 60 of 91 children with urgency did not have evidence of an overactive bladder during bladder filling, and 47 of 100 children with a history consistent with non-neurogenic dysfunctional voiding did not have increased pelvic floor activity during voiding. In addition, there was poor correlation between the response to treatment with urodynamic findings. Although editorial comments raised concerns about this study, including the reliability of the clinical diagnoses and technical consistency of the urodynamic testing, these findings highlight the lack of accurate methods to identify the cause of all bladder dysfunction symptoms.",
"   </p>",
"   <p>",
"    Nevertheless, urodynamic testing is a currently available modality that identifies functional voiding abnormalities in most children with daytime incontinence who fail conservative therapy. It is rarely required because most cases of bladder dysfunction are due to functional causes in which behavioral therapy is successful in bladder function retraining and improvement of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/25\">",
"     25",
"    </a>",
"    ]. In those patients, it may identify a bladder functional abnormality to direct individualized therapy.",
"   </p>",
"   <p>",
"    Urodynamic testing is generally reserved for the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A known or suspected neurologic lesion.",
"     </li>",
"     <li>",
"      Severe bladder dysfunction with evidence of renal damage or hydronephrosis.",
"     </li>",
"     <li>",
"      High imperforate anus.",
"     </li>",
"     <li>",
"      Selected cases of abnormal urinary tract anatomy, such as posterior urethral valves.",
"     </li>",
"     <li>",
"      Children with suspected functional bladder dysfunction that is refractory to treatment in whom the diagnosis still remains uncertain after urologic imaging and urinary flow measurement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Urodynamic patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although standard values are available for urodynamic studies in children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/26\">",
"     26",
"    </a>",
"    ], care must be taken in interpreting the results, especially in infants in whom reported transient urodynamic dysfunction has improved over time [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Voiding disorders and their urodynamic findings include the following (",
"    <a class=\"graphic graphic_table graphicRef65207 \" href=\"UTD.htm?15/12/15564\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overactive bladder &mdash; Children with an overactive bladder have involuntary detrusor contractions during the filling phase, referred to as detrusor overactivity, with increase bladder pressure of more than 15 cm H2O. There are no other voiding abnormalities; these children have normal sphincter activity during both the filling and voiding phases, and normal detrusor contractions during voiding. In case series of children with voiding dysfunction symptoms, detrusor overactivity detected by urodynamic testing is present in 52 to 58 percent of patients compared to only 5 to 18 percent of asymptomatic children [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/26,28-30\">",
"     26,28-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dysfunctional voiding &ndash; This disorder occurs in children with a neurologic lesion, referred to as detrusor sphincter dyssynergy, or in neurologic intact patients, referred to as non-neurogenic dysfunctional voiding. In both groups of children, there is abnormal contraction of the urethral sphincter during voiding. These children have normal detrusor function during both the filling and voiding phases, and normal sphincter contraction during the filling phase. However, there is a subgroup of children with dysfunctional voiding that also have an overactive bladder [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25384/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Underactive bladder &ndash; Children with an underactive bladder have a large capacity bladder and incomplete emptying of the bladder during voiding because of inadequate detrusor contraction. These children have normal sphincter function during both the filling and voiding phases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/2/21538?source=see_link\">",
"       \"Patient information: Daytime wetting (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder dysfunction, defined as an abnormality in either filling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emptying the bladder, is a common problem in children. Bladder dysfunction, particularly daytime urinary incontinence, can be a source of major stress in school-age children. Thus, it is desirable to identify and treat affected children as early as possible.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The goal of evaluating a child suspected of having bladder dysfunction is to confirm the presence or absence of an abnormality in bladder function and, if present, determine the underlying cause. In particular, evaluation should distinguish organic (ie, neurologic and anatomic) from functional causes of bladder dysfunction. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Overview'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'When to suspect bladder dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The components of the initial evaluation are a thorough history, focused physical examination, and laboratory testing that includes urinalysis, urine culture, and, in some children, serum creatinine.",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of bladder dysfunction is based upon the presence of one or more voiding symptoms that include urgency, hesitancy, dribbling, use of holding maneuvers to suppress voiding, abnormality of urinary flow including weak or intermittent urinary stream, and the use of abdominal straining during voiding. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=see_link&amp;anchor=H2#H2\">",
"       \"Etiology and clinical features of bladder dysfunction in children\", section on 'Definitions of symptoms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The underlying cause of bladder dysfunction is often suggested by a constellation of signs and symptoms detected during the initial evaluation. Most cases are due to a functional cause (eg, overactive or underactive bladder), and in these children, behavioral therapeutic interventions aimed at retraining the bladder can be initiated based upon a clinical diagnosis. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Initial evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Further evaluation includes imaging of the urinary tract, measurement of urinary flow, and urodynamic testing. These studies are generally reserved for patients suspected of having a neurologic or anatomic etiology, patients who are not responsive to behavioral modification therapy, or who have constant continuous incontinence, urinary tract infection, vesicoureteral reflux, or suspected renal damage. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Further evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=see_link\">",
"       \"Urinary tract complications of myelomeningocele (spina bifida)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/1\">",
"      Farhat W, B&auml;gli DJ, Capolicchio G, et al. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 2000; 164:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/2\">",
"      Anderson GE, Jimerson SR, Whipple AD. Student Ratings of Stressful Experiences at Home and School: Loss of a Parent and Grade Retention as Superlative Stressors. Journal of Applied School Psychology 2005; 21:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/3\">",
"      Ollendick TH, King NJ, Frary RB. Fears in children and adolescents: reliability and generalizability across gender, age and nationality. Behav Res Ther 1989; 27:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/4\">",
"      H&auml;ggl&ouml;f B, Andr&eacute;n O, Bergstr&ouml;m E, et al. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol 1998; 33 Suppl 3:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/5\">",
"      von Gontard A, Lettgen B, Olbing H, et al. Behavioural problems in children with urge incontinence and voiding postponement: a comparison of a paediatric and child psychiatric sample. Br J Urol 1998; 81 Suppl 3:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/6\">",
"      Duel BP, Steinberg-Epstein R, Hill M, Lerner M. A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder. J Urol 2003; 170:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/7\">",
"      Robson WL, Jackson HP, Blackhurst D, Leung AK. Enuresis in children with attention-deficit hyperactivity disorder. South Med J 1997; 90:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/8\">",
"      Hoebeke P, Van Laecke E, Raes A, et al. Anomalies of the external urethral meatus in girls with non-neurogenic bladder sphincter dysfunction. BJU Int 1999; 83:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/9\">",
"      Ellsworth PI, Merguerian PA, Copening ME. Sexual abuse: another causative factor in dysfunctional voiding. J Urol 1995; 153:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/10\">",
"      Nev&eacute;us T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol 2006; 176:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/11\">",
"      Chang SJ, Yang SS. Variability, related factors and normal reference value of post-void residual urine in healthy kindergarteners. J Urol 2009; 182:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/12\">",
"      Jequier S, Rousseau O. Sonographic measurements of the normal bladder wall in children. AJR Am J Roentgenol 1987; 149:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/13\">",
"      Yeung CK, Sreedhar B, Leung YF, Sit KY. Correlation between ultrasonographic bladder measurements and urodynamic findings in children with recurrent urinary tract infection. BJU Int 2007; 99:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/14\">",
"      Allen HA, Austin JC, Boyt MA, et al. Evaluation of constipation by abdominal radiographs correlated with treatment outcome in children with dysfunctional elimination. Urology 2007; 69:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/15\">",
"      Arikan N, Soyg&uuml;r T, Sel&ccedil;uki M, et al. Role of magnetic resonance imaging in children with voiding dysfunction: retrospective analysis of 81 patients. Urology 1999; 54:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/16\">",
"      Wraige E, Borzyskowski M. Investigation of daytime wetting: when is spinal cord imaging indicated? Arch Dis Child 2002; 87:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/17\">",
"      Van Arendonk KJ, Austin JC, Boyt MA, Cooper CS. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder. Urology 2006; 67:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/18\">",
"      Nelson JD, Cooper CS, Boyt MA, et al. Improved uroflow parameters and post-void residual following biofeedback therapy in pediatric patients with dysfunctional voiding does not correspond to outcome. J Urol 2004; 172:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/19\">",
"      Allen HA, Austin JC, Boyt MA, et al. Initial trial of timed voiding is warranted for all children with daytime incontinence. Urology 2007; 69:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/20\">",
"      Yamanishi T, Yasuda K, Murayama N, et al. Biofeedback training for detrusor overactivity in children. J Urol 2000; 164:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/21\">",
"      Koff SA. Estimating bladder capacity in children. Urology 1983; 21:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/22\">",
"      Van Arendonk KJ, Knudson MJ, Austin JC, Cooper CS. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin. Urology 2006; 68:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/23\">",
"      Kaufman MR, DeMarco RT, Pope JC 4th, et al. High yield of urodynamics performed for refractory nonneurogenic dysfunctional voiding in the pediatric population. J Urol 2006; 176:1835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/24\">",
"      Bael A, Lax H, de Jong TP, et al. The relevance of urodynamic studies for Urge syndrome and dysfunctional voiding: a multicenter controlled trial in children. J Urol 2008; 180:1486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/25\">",
"      Herndon CD, Decambre M, McKenna PH. Interactive computer games for treatment of pelvic floor dysfunction. J Urol 2001; 166:1893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/26\">",
"      Wen JG, Tong EC. Cystometry in infants and children with no apparent voiding symptoms. Br J Urol 1998; 81:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/27\">",
"      Chandra M, Maddix H, McVicar M. Transient urodynamic dysfunction of infancy: relationship to urinary tract infections and vesicoureteral reflux. J Urol 1996; 155:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/28\">",
"      Schulman SL, Quinn CK, Plachter N, Kodman-Jones C. Comprehensive management of dysfunctional voiding. Pediatrics 1999; 103:E31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/29\">",
"      Hoebeke P, Van Laecke E, Van Camp C, et al. One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int 2001; 87:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/30\">",
"      Yeung CK, Godley ML, Duffy PG, Ransley PG. Natural filling cystometry in infants and children. Br J Urol 1995; 75:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25384/abstract/31\">",
"      Nijman RJ. Classification and treatment of functional incontinence in children. BJU Int 2000; 85 Suppl 3:37.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6577 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-9F549ED38C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25384=[""].join("\n");
var outline_f24_50_25384=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      WHEN TO SUSPECT BLADDER DYSFUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Voiding diary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      FURTHER EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Voiding cystourethrogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Urinary flow measurement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Shape of urine flow curve",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Other parameters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Urodynamic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Urodynamic patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6577\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6577|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/55/11125\" title=\"figure 1\">",
"      Normal urinary voiding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/60/35791\" title=\"figure 2\">",
"      Urinary flow patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6577|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/12/15564\" title=\"table 1\">",
"      Urodynamic patterns",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/63/15354?source=related_link\">",
"      Constipation in children: Etiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24312?source=related_link\">",
"      Diagnosis of polyuria and diabetes insipidus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28793?source=related_link\">",
"      Etiology and clinical features of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41785?source=related_link\">",
"      Management of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/2/21538?source=related_link\">",
"      Patient information: Daytime wetting (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/10/3242?source=related_link\">",
"      Presentation, diagnosis, and clinical course of vesicoureteral reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/59/15288?source=related_link\">",
"      Urinary tract complications of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_50_25385="Radiologic evaluation of the chronically painful knee in adults";
var content_f24_50_25385=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Radiologic evaluation of the chronically painful knee in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Shahla Modarresi, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Cecilia M Jude, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Robert H Shmerling, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25385/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/50/25385/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The knee is one of the largest and most complex joints in the body. It is lined by synovium and consists of two hinge-type joints between the femoral condyles and the medial and lateral tibial plateaus and a gliding-type joint between the patella and the trochlear groove of the anterior distal femur (",
"    <a class=\"graphic graphic_figure graphicRef69611 \" href=\"UTD.htm?34/27/35251\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/1\">",
"     1",
"    </a>",
"    ]. The major stabilizers of the joint are the extensor tendons (quadriceps and patellar tendons), medial and lateral collateral ligament complex, and cruciate ligaments. The menisci are fibrocartilaginous structures that distribute the stress over the articular cartilage, absorb the shock in axial loading, stabilize the joint in flexion and extension, and have a role in joint lubrication [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For the purposes of this discussion, &ldquo;chronic knee pain&rdquo; is defined as pain of at least three months&rsquo; duration. Imaging modalities used to evaluate adults with chronic knee pain and the appropriateness of particular studies in different clinical scenarios will be reviewed here. The history and physical examination, which are necessary to develop a differential diagnosis prior to the selection of imaging tests, a general review of imaging tests that are used in the evaluation of bone and joint pain, and radiologic evaluation of adults with acute knee pain are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link\">",
"     \"Evaluation of the active adult patient with knee pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/7/3193?source=see_link\">",
"     \"Diagnostic imaging of joint pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12489?source=see_link\">",
"     \"Radiologic evaluation of the acutely painful knee in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic knee pain is most commonly caused by arthritis, bursitis and cystic lesions around the joint, tendon pathology, cartilage pathology, chronic infection, osteonecrosis (avascular necrosis), stress fractures, and avulsion injuries.",
"   </p>",
"   <p>",
"    Referred pain is an important clinical consideration in the patient with chronic knee pain; however, knee pain that is referred from other anatomic sites is beyond the scope of our discussion and is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link&amp;anchor=H29#H29\">",
"     \"Evaluation of the active adult patient with knee pain\", section on 'Referred pain syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of imaging in the assessment of children and adolescents with knee pain is also presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5273?source=see_link&amp;anchor=H23#H23\">",
"     \"Approach to the young athlete with acute knee pain or injury\", section on 'Radiographic evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29223?source=see_link&amp;anchor=H22#H22\">",
"     \"Approach to the young athlete with chronic knee pain or injury\", section on 'Radiography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ARTHRITIDES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major arthritides involving the knee joint include osteoarthritis, calcium pyrophosphate deposition disease, and inflammatory arthritides such as rheumatoid arthritis, psoriatic arthritis, reactive arthritis (formerly Reiter&rsquo;s syndrome), and peripheral arthritis in patients with ankylosing spondylitis. Less common arthritides that cause chronic knee pain such as neuropathic arthropathy, gout, and hemophilic arthropathy are discussed below.",
"   </p>",
"   <p>",
"    As noted above, the knee joint consists of three compartments: the medial tibiofemoral, the lateral tibiofemoral and the patellofemoral compartment. These compartments are affected differently by various arthropathies.",
"   </p>",
"   <p>",
"    Plain film radiography is the initial imaging modality of choice for evaluation of all arthritides and in most cases the only study required for diagnosis. Magnetic resonance imaging (MRI) has some value for evaluation of arthritides, which will be discussed below under individual entities. MRI can differentiate between proliferating synovium and joint effusion, and quantifies synovial volume. The latter is valuable in assessing severity of the disease and response to therapy in clinical trials. MRI and ultrasonography may be useful in directing synovial biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Computer-aided tomography (CT) and CT arthrography may be alternative imaging studies when MRI is contraindicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Osteoarthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteoarthritis (OA) is the most common arthropathy seen in the knee. OA can be primary or secondary to prior joint injury or infection, osteonecrosis, inflammatory and crystal-induced arthropathies, metabolic disorders, or hemophilia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=see_link\">",
"     \"Diagnosis and classification of osteoarthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plain film radiography is the initial, and is often the only, imaging modality needed to diagnose OA and exclude other causes of knee pain. The presence of articular calcification may be a clue to the presence of OA due to underlying endocrine, metabolic, or inherited disorder (see",
"    <a class=\"local\" href=\"#H4\">",
"     'Calcium pyrophosphate deposition disease'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiographs are not sensitive for detection of early cartilage loss associated with arthritis. Hallmarks of OA of the knee seen in plain film include osteophyte formation, joint space narrowing, subchondral sclerosis, and subchondral cyst formation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef74675 \" href=\"UTD.htm?39/36/40527\">",
"       image 1",
"      </a>",
"      ). Osteophyte formation is the most specific sign for detection of OA [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/4\">",
"       4",
"      </a>",
"      ]. Joint effusion can also be present. Advanced manifestations of osteoarthritis include complete loss of joint space, osteochondral loose bodies, and Baker's cyst formation. Other degenerative changes in the knee can occur at the insertion of the quadriceps or patellar tendon on the patella, leading to enthesopathy (ossification of the tendon attachment).",
"     </li>",
"     <li>",
"      CT &mdash; CT is more sensitive for showing early bony changes of osteoarthritis, however, it is not routinely indicated. CT can help in detection of radiographically occult loose bodies.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is not recommended in the presence of advanced OA seen on plain radiographs. In early OA, MRI may provide additional information about the extent of bone and soft tissue involvement, such as subchondral bone marrow edema, extent of cartilage damage, meniscal and ligament tears, synovitis, osteochondral loose bodies, and Baker&rsquo;s cyst [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/5\">",
"       5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      However, MRI often reveals abnormal findings even in asymptomatic patients without radiographic OA. In a study of 710 patients over age 50 without radiographic evidence of OA, the most common changes on MRI examination of the tibiofemoral joint were osteophytes, cartilage damage, and bone marrow abnormalities (in 74, 69, and 52 percent, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/6\">",
"       6",
"      </a>",
"      ]. Moreover, at least one finding was present in similar numbers of patients with or without pain (90 to 97 percent and 86 to 88 percent, depending upon the pain definition used). Changes were more common with advancing age. Thus, MRI is generally not useful in routine clinical practice for the evaluation of OA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several of the above findings correlate with severity of knee pain in patients with OA. These include synovitis, joint effusion, ligament tears such as anterior cruciate ligament (ACL) tear, and subchondral bone marrow edema [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Subchondral bone marrow edema also correlates with progression of OA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/8,10,11\">",
"     8,10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Degenerative meniscal tears appear to be an early event in development of OA as shown by several studies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. However, degenerative meniscal tears are highly prevalent in both symptomatic and asymptomatic osteoarthritic knees and MRI is not indicated in the evaluation and management of these tears in patients with OA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Changes in cartilage volume also appear to be associated with clinical symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/16\">",
"     16",
"    </a>",
"    ]. Studies using quantitative techniques emphasize the ability of MRI to accurately measure the progression of knee OA by assessing changes in cartilage volume. This in turn could be helpful in following the effect of treatment with structure-modifying agents in clinical trials, or in selecting patients at high risk for requiring joint replacement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/16-19\">",
"     16-19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Calcium pyrophosphate deposition disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calcium pyrophosphate deposition disease (CPPD) is caused by deposition of calcium pyrophosphate dihydrate crystal in and around the joints. CPPD is the second most common arthropathy of the knee, seen predominantly in the middle and older age group. CPPD is often asymptomatic and diagnosed on plain film by articular cartilage or meniscal calcification (chondrocalcinosis). When symptomatic, CPPD is also called pseudogout. Joint aspiration may be necessary to obtain synovial fluid to confirm the presence of CPPD crystals and to exclude infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7785?source=see_link\">",
"     \"Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Thin calcification (chondrocalcinosis) is present in the articular cartilage or menisci (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef66550 \" href=\"UTD.htm?35/3/35902\">",
"       image 2",
"      </a>",
"      ), with preferential involvement of the patellofemoral joint. Calcifications of the synovium, tendon, and ligaments can also be seen. CPPD may lead to the early development of secondary osteoarthritis. Isolated patellofemoral involvement in the knee should suggest the possibility of CPPD arthropathy. Definitive diagnosis of CPPD arthropathy also requires the demonstration of positively (but weakly) birefringent CPPD crystals in tissue or synovial fluid.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Rheumatoid arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common inflammatory arthritis of the knee is rheumatoid arthritis (RA). Women are more commonly affected than men. The knees are involved in 80 percent of the patients with RA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/20\">",
"     20",
"    </a>",
"    ]. The presence of a popliteal (Baker's) cyst (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Popliteal bursitis'",
"    </a>",
"    below) is a common occurrence in RA.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Characteristic findings of RA on plain film are bilaterally symmetric and uniform joint space narrowing involving all three compartments (medial and lateral tibiofemoral and patellofemoral), periarticular osteoporosis, soft tissue swelling and joint effusion. Large synovial cysts may be present. Erosion is not a predominant characteristic in the knee and there is relative lack of sclerosis and osteophyte formation.",
"     </li>",
"     <li>",
"      CT &mdash; CT demonstrates erosions earlier than plain film; however, CT is not routinely used for evaluation of RA. CT better demonstrates the degree of joint destruction as compared to plain films. CT differentiates synovial proliferation from joint effusion.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI demonstrates early changes of RA manifested by synovitis before plain film evidence of disease. The extent of synovitis in early RA is the best predictor of development of erosions [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/21\">",
"       21",
"      </a>",
"      ]. MRI shows the degree of synovial hypertrophy (pannus formation), which correlates with disease activity. MRI identifies involvement of the cartilage, tendon, and ligaments. MRI is useful in demonstrating the presence of loose bodies and Baker's cyst, which may complicate RA. Despite these advantages, the role of MRI in the diagnosis and monitoring of RA is still uncertain. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6010?source=see_link&amp;anchor=H8594869#H8594869\">",
"       \"Diagnosis and differential diagnosis of rheumatoid arthritis\", section on 'Evaluation for suspected RA'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39098?source=see_link\">",
"       \"General principles of management of rheumatoid arthritis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Psoriatic arthritis and reactive arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoriatic and reactive arthritis (formerly the arthritis of Reiter's syndrome) have similar radiographic findings in the knee. Asymmetric involvement is a common feature. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=see_link\">",
"     \"Clinical manifestations and diagnosis of psoriatic arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=see_link\">",
"     \"Reactive arthritis (formerly Reiter syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is the single most important technique for detection, diagnosis, and follow-up of reactive arthritis. Typical findings include osteophyte and enthesophyte formation (bone proliferation at the ligamentous and tendinous attachments) and periostitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ankylosing spondylitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the axial skeleton (spine and sacroiliac joints). It is more commonly seen in young men. Knee involvement is uncommon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"     \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is the single most important technique for detection, diagnosis, and follow-up of patients with ankylosing spondylitis and knee involvement. Uniform joint space narrowing, small erosions, and bone sclerosis are seen early in the disease, which may lead to ankylosis of the entire joint.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Neuropathic arthropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuropathic arthropathy, also known as Charcot joint, is caused by chronic conditions causing neurosensory deficit such as diabetes, syphilis, and syringomyelia. The lower extremity, including the hip and knee, is involved in 60 to 70 percent of patients with tabes dorsalis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/22\">",
"     22",
"    </a>",
"    ]. Charcot joint is characterized by fragmentation of bone and cartilage with increased density and disorganization of the joint.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiographic findings of neuropathic arthropathy include large recurrent joint effusions, joint subluxations, pathological fractures and bone debris in the joint, leading to complete derangement of the joint.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Gouty arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gout affects men significantly more than women. The knee is the third most commonly affected joint, after the foot and ankle. Plain film radiography changes in gout appear in approximately 45 percent of the patients, six to eight years after the initial attack [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Urate crystal deposition in the articular cartilage leads to secondary osteoarthritis. Urate crystals can also deposit in the soft tissues in the form of tophi, which in turn cause erosion of the adjacent bone with typical sclerotic border and overhanging edges. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=see_link\">",
"     \"Clinical manifestations and diagnosis of gout\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography of gouty arthritis or tophaceous gout can show periarticular soft tissue masses with occasional internal calcifications and possible adjacent erosions. When the knee is affected, osteoarthritic changes predominate [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MRI &mdash; MRI shows gouty erosions earlier than plain film radiography, demonstrates presence of tophi and differentiates suprapatellar soft tissue masses from joint effusion. Tophi characteristically have relatively homogeneous intermediate or low-signal intensity on T1-weighted images and variable signal intensity on T2-weighted images [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Hemophilic arthropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Joint changes in hemophilia are secondary to repeated hemarthrosis (joint hemorrhage) and intraosseous bleeding, which occur in 75 to 90 percent of patients. Articular changes occur most often in the first and second decade of life. The knee is the most commonly involved joint, with 50 percent of the patients developing permanent bone changes around the joint [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/25\">",
"     25",
"    </a>",
"    ]. The radiographic findings can mimic juvenile idiopathic arthritis. MRI findings can mimic those of pigmented villonodular synovitis (PVNS) due to intraarticular hemosiderin deposition in both entities. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/18/1322?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical manifestations and diagnosis of hemophilia\", section on 'Hemophilic arthropathy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/10/42150?source=see_link&amp;anchor=H5#H5\">",
"     \"Antineoplastic therapy for miscellaneous benign diseases affecting soft tissue and bone\", section on 'Pigmented villonodular synovitis/tenosynovial giant cell tumor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; In acute hemarthrosis, joint effusion and osteoporosis are present. Chronic hyperemia in the joint leads to overgrowth of the tibial and femoral epiphyses, causing widening of the intercondylar notch. Overgrowth and squaring of the patella is present. Subchondral cyst formation is seen secondary to intraosseous bleeding. In the chronic phase, there is secondary osteoarthritis with uniform joint space narrowing.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is indicated for determining the extent of cartilage destruction and synovial thickening, which affect management. Hemosiderin deposition due to chronic joint hemorrhage in hemophilia may result in clumps of low T1-weighted and low T2-weighted signal lining the synovium. The presence of hemosiderin is associated with advanced joint destruction. MRI is important in assessment of response to therapy and disease progression [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     BURSITIS AND CYSTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bursae around the knee joint most commonly involved by pathology include the popliteal bursa, prepatellar bursa, and pes anserinus bursa. Less commonly involved bursae are the supra- and infrapatellar bursae, semimembranosus tibial collateral ligament bursa, tibial collateral ligament bursa, iliotibial band bursa, and fibular collateral ligament-biceps femoris bursae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Bursitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bursae around the knee can become inflamed and mimic intraarticular pathology. The bursae around the joint are not seen arthroscopically, and ultrasound (US) is useful in evaluation of pes anserinus bursitis and Baker's cyst. MRI is the modality of choice for imaging evaluation of suspected bursal pathology in other knee bursae. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28422?source=see_link\">",
"     \"Knee bursitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Popliteal bursitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most commonly inflamed bursa of the knee is the popliteal bursa, also known as Baker's cyst. Baker's cyst is commonly associated with meniscal tears and other causes of internal derangement of the joint. Baker's cyst is also associated with arthropathies, including osteoarthritis and rheumatoid arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27016?source=see_link\">",
"     \"Popliteal (Baker's) cyst\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Baker's cyst may extend superiorly or inferiorly and can cause compartment syndrome. It can cause pressure on the venous system and lead to edema or thrombophlebitis. MRI (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64221 \" href=\"UTD.htm?27/41/28304\">",
"     image 3",
"    </a>",
"    ) or ultrasound (US) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50397 \" href=\"UTD.htm?40/58/41888\">",
"     image 4",
"    </a>",
"    ) is diagnostic. Rupture of the cyst with extravasation in the surrounding muscle may mimic thrombophlebitis. Thus, if there is suspicion of venous thrombosis the use of US to both assess for proximal clot and for the presence of an intact or ruptured Baker's cyst is appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/12/33994?source=see_link&amp;anchor=H13#H13\">",
"     \"Diagnosis of suspected deep vein thrombosis of the lower extremity\", section on 'Compression ultrasonography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Prepatellar bursitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prepatellar bursitis is a common etiology of anterior knee pain that can be caused by repetitive trauma from kneeling, also referred to as \"housemaid's knee\". Although MRI can be diagnostic (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79005 \" href=\"UTD.htm?23/11/23743\">",
"     image 5",
"    </a>",
"    ), clinical examination alone augmented with bursal aspiration usually suffices for diagnosis of this superficial bursitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Pes anserinus bursitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pes anserinus bursitis is commonly seen in runners, can clinically mimic medial meniscal tear, and present as anteromedial knee pain. The pes tendon is formed by the sartorius, gracilis, and semitendinosus tendons, which insert medially in the upper tibia. While MRI is diagnostic and ultrasound can also be useful, the diagnosis can usually be established clinically, without imaging studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cysts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Popliteal bursal swelling (Baker's cyst) is one type of cystic swelling that occurs near the knee joint (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Popliteal bursitis'",
"    </a>",
"    above). The other two types that are commonly found in this location are ganglion cysts and meniscal cysts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Ganglion cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;A ganglion is a cystic benign tumor of unknown origin. Ganglion cysts may be juxta-articular, intra-articular, and periosteal. A juxta-articular ganglion cyst is a common entity within the soft tissue around the knee, which can be asymptomatic or present with pain or nerve entrapment symptoms. Intra-articular ganglions are less common and may be asymptomatic or present with pain, locking, clicking, or popping, and decreased range of motion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/26\">",
"     26",
"    </a>",
"    ]. Periosteal ganglions are rare. Magnetic resonance imaging is the study of choice for detection of ganglion cysts and demonstrates a cystic mass [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/27\">",
"     27",
"    </a>",
"    ]. When present, ganglion cysts may be unilocular or multilocular [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Meniscal cyst",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meniscal cyst is a collection of synovial fluid within or adjacent to the meniscus, and is most often associated with meniscal tear. Symptoms include swelling, palpable mass, pain and decreased range of motion. MRI demonstrates a cystic mass and detects associated meniscal tear [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     TENDON PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two knee tendons most frequently involved by tendinosis are the quadriceps and patellar tendons. The spectrum of tendon abnormalities includes degeneration, tendinosis, tenosynovitis, and partial or complete tears. Factors that predispose to tendon tears are chronic repetitive stress, tendon degeneration, inflammatory process of the tendon (such as rheumatoid arthritis, other inflammatory arthropathies, and chronic infection of tendon sheath), chronic renal disease, chronic glucocorticoid use, diabetes, and gout.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MRI &mdash; The imaging modality of choice for evaluating tendon pathology is MRI. MRI of normal tendons demonstrates low signal (dark appearance) on all MRI sequences (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef51776 \" href=\"UTD.htm?17/37/18000\">",
"       image 6",
"      </a>",
"      ). One exception in the knee is the quadriceps tendon, which normally exhibits a striated appearance of low and intermediate signal intensity.",
"      <br/>",
"      <br/>",
"      On MRI, tendinosis appears as intermediate increased signal (bright) on both T1-weighted and T2-weighted images. Tendinosis can lead to either partial tear with disruption of some fibers of the tendon, (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78685 \" href=\"UTD.htm?20/54/21345\">",
"       image 7",
"      </a>",
"      ) or to complete tear with discontinuity of the entire tendon (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82182 \" href=\"UTD.htm?26/11/26800\">",
"       image 8",
"      </a>",
"      ). MRI demonstrates the quality of the remnants of tendon in complete tear, degree of separation of tendon fragments, and resultant muscle atrophy, which affect management.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ARTICULAR CARTILAGE PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In settings other than radiographically advanced OA (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Osteoarthritis'",
"    </a>",
"    above), MRI is the modality of choice in demonstrating abnormal articular cartilage in the knee. Focal defects in the articular cartilage surface may result from trauma to the knee. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12489?source=see_link&amp;anchor=H4#H4\">",
"     \"Radiologic evaluation of the acutely painful knee in adults\", section on 'Acute chondral and osteochondral injuries'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CT arthrography &mdash; CT arthrography and MRI are equally accurate in diagnosing cartilage damage. For larger lesions, CT arthrography has higher specificity than MRI [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/28\">",
"       28",
"      </a>",
"      ]. CT arthrography is diagnostic of cartilage tear by showing penetration of contrast material within the cartilage substance.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI demonstrates the spectrum of cartilage abnormalities, from focal abnormal signal, to surface fibrillation or irregularity, partial thickness defect or full thickness defect. MRI also demonstrates underlying bone signal abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     MENISCAL CARTILAGE PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Degenerative changes in the fibrocartilagenous menisci increase with age. Thus, radiographic findings, particularly increased signal within the body of the meniscus must be interpreted with caution. Clinically important meniscal tears may be found in patients with knee pain without a history of trauma. However, meniscal tears may also be noted in otherwise healthy persons with no knee pain.",
"   </p>",
"   <p>",
"    Chronic knee pain with mechanical symptoms such as locking or an inability to fully extend the knee, popping, giving way, or \"not moving properly\" may indicate a clinically significant meniscal tear. Patients for whom surgical intervention would be indicated if a meniscal tear is present are best evaluated with MRI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=see_link&amp;anchor=H10#H10\">",
"     \"Meniscal injury of the knee\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MRI &mdash; MRI demonstrates the spectrum of meniscal pathology, from myxoid degeneration to complete tear. Tears of the medial meniscus are common sports-related injuries. Tears of the lateral meniscus are less common. Lateral meniscal tears are commonly associated with discoid meniscus, a developmental anomaly. Horizontal or oblique meniscal tears are frequently seen in both symptomatic and asymptomatic knees, and the prevalence of MRI-detected tears in asymptomatic knees increases markedly with age.",
"      <br/>",
"      <br/>",
"      However, radial, vertical, complex, or displaced meniscal tears are almost always symptomatic. Meniscal tear is present when abnormal intrameniscal MRI signal disrupts the articular surface (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef65888 \" href=\"UTD.htm?14/4/14415\">",
"       image 9",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      MR arthrography &mdash; MR arthrography is indicated in the postsurgical evaluation of meniscal retear following prior partial meniscectomy or meniscal repair.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     CHRONIC INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic infection may occur in the knee joint or in the juxta-articular bone. Mycobacterial and fungal infections in either site may be indolent but can cause progressive joint damage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Chronic infectious arthritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to gram positive or gram negative bacterial joint infections, which typically present acutely, mycobacterial and fungal arthritis may have more subtle symptoms and patients with arthritis of the knee due to organisms such as mycobacterium tuberculosis, Candida species, and Coccidioides immitis can present with chronic monoarthritis of the knee. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=see_link\">",
"     \"Skeletal tuberculosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/25/11671?source=see_link\">",
"     \"Candida osteoarticular infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=see_link\">",
"     \"Manifestations and treatment of extrapulmonary coccidioidomycosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; There are no findings on plain films of the knee that are specific for mycobacterial or fungal infection. Relative preservation of the joint space in the presence of adjacent bone destruction has been suggested as a clue to articular tuberculosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=see_link&amp;anchor=H8#H8\">",
"       \"Skeletal tuberculosis\", section on 'Arthritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      MRI &mdash; MRI features of tuberculous arthritis of the knee include synovial proliferation with intermediate to low T2-weighted signal and synovial enhancement following intravenous contrast [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Chronic osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advantages and limitations of various imaging studies in the assessment of suspected chronic osteomyelitis are summarized below and are discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12071?source=see_link\">",
"     \"Approach to imaging modalities in the setting of suspected osteomyelitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Chronic osteomyelitis presents with a mixed pattern of lysis, sclerosis, and cortical thickening. Sequestrum formation (necrotic bone), involucrum (thick, irregular periosteal reaction), cloacae (cortical defects), and sinus tract can also be present.",
"     </li>",
"     <li>",
"      CT &mdash; CT is indicated in chronic osteomyelitis to evaluate the extent of the disease such as sequestrum, involucrum, cloacae, sinus tract, and soft tissue swelling. CT is considered superior to MR imaging in the setting of chronic active osteomyelitis for the demonstration of cortical destruction and gas. The most specific sign of active chronic osteomyelitis is the presence of a sequestrum, which is best demonstrated on CT, although the viability of sequestered bone is more reliably determined with MR imaging [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is more sensitive than CT in demonstrating activity of the disease in chronic osteomyelitis. MRI demonstrates most features of chronic active osteomyelitis, including the presence of sequestrum, intramedullary abscess, cloaca, subperiosteal fluid collection, and sinus tract formation. Serial MRI demonstrates the progression or regression of chronic infection.",
"     </li>",
"     <li>",
"      Radionuclide scintigraphy &mdash; Nuclear imaging may be useful if CT and MRI are contraindicated. Bone scanning, gallium scanning, and tagged white blood cell scanning are among the options available.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     OSTEONECROSIS (AVASCULAR NECROSIS OF BONE)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteonecrosis, also known as avascular necrosis of bone (AVN), frequently affects the knee, which is the third most commonly involved joint after the hip and shoulder. Osteonecrosis of the knee develops in adults secondary to underlying disease or predisposing factors such as steroid use, alcoholism, connective tissue disorders (systemic lupus erythematosus), hemoglobinopathies, and HIV. Osteonecrosis is usually asymptomatic in the knee, unless epiphyseal collapse occurs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=see_link\">",
"     \"Osteonecrosis (avascular necrosis of bone)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The femoral condyles are more commonly involved, although any area around the knee can be affected. Plain film radiography findings range from normal to radiolucent subchondral area to epiphyseal collapse. MRI demonstrates a geographic focus of heterogeneous signal surrounded by low signal on T1-weighted images and by a double line on T2-weighted images. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=see_link&amp;anchor=H23#H23\">",
"     \"Osteonecrosis (avascular necrosis of bone)\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Spontaneous osteonecrosis of the knee (SONK) is commonly seen in older adults, eg, in the sixth and seventh decade, more often in women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Spontaneous osteonecrosis may result from trauma, oral or intra-articular steroid administration, systemic disease such as lupus erythematosus, and meniscal tears. The most common location is the medial aspect of the medial femoral condyle, which is a weight-bearing segment. Other locations such as medial tibial plateau and patella have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; The radiographic appearance of osteonecrosis of the medial femoral condyle ranges from mild flattening of the condyle to subchondral lucency, later surrounded by sclerosis.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI should always be performed to exclude predisposing meniscal tears. MRI is useful for the early detection of spontaneous osteonecrosis of the knee and has prognostic significance by identifying the lesions that are likely to resolve with conservative treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Osteochondritis dissecans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteochondritis dissecans is a relatively common entity seen in adolescents and young adults, more often in men [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/34\">",
"     34",
"    </a>",
"    ]. Osteochondritis dissecans is a result of chronic microtrauma and represents a form of avascular necrosis that is small and focal. The most common location is the lateral aspect of the medial femoral condyle, which is a non-weightbearing segment. The clinical manifestations, diagnosis, and management of osteochondritis dissecans affecting the knee (and other joints) are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13913?source=see_link\">",
"     \"Clinical manifestations and diagnosis of osteochondritis dissecans (OCD)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19014?source=see_link\">",
"     \"Management of osteochondritis dissecans (OCD)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Joint effusion may be the only initial radiographic finding. The classic finding is a radiolucent line separating the osteochondral fragment from the femoral condyle. This can lead to complete separation of the fragment into an intraarticular loose body.",
"     </li>",
"     <li>",
"      MR imaging and MR arthrography &mdash; MR imaging demonstrates abnormal signal in the lateral aspect of the medial femoral condyle due to osteochondral fracture (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef57547 \" href=\"UTD.htm?22/44/23232\">",
"       image 10",
"      </a>",
"      ). MR arthrography may be helpful in assessing the stability of the osteochondral fragment.",
"     </li>",
"     <li>",
"      CT arthrography &mdash; CT arthrography with intraarticular iodinated contrast may be useful in cases when MRI is contraindicated (eg, metallic foreign body around the knee, pacemaker, aneurysm clip). CT arthrography detects chondral injuries and can be helpful in assessing the stability of the osteochondral fragment in osteochondritis dissecans.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     STRESS AND INSUFFICIENCY FRACTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress and insufficiency fractures are defined and discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=see_link\">",
"     \"Overview of stress fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Plain film radiographs are the initial modality of choice for the evaluation of suspected stress and insufficiency fractures. However, MRI, radionuclide imaging, and CT are all more sensitive than plain radiographs for the detection of such fractures, particularly during the first few weeks following the onset of pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Stress and insufficiency fractures are often not visualized in the first two weeks on plain radiographs. The sensitivity of early radiographs is as low as 15 percent, increasing to 50 percent in follow-up radiographs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/35\">",
"       35",
"      </a>",
"      ]. When stress or insufficiency fracture is clinically suspected, further evaluation with MRI is warranted. Development of radiographic findings can be prevented by cessation of physical activity. Stress and insufficiency fractures appear as periosteal reaction",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      horizontal band of sclerotic density in the tibial metaphysis.",
"     </li>",
"     <li>",
"      MRI &mdash; MRI is the modality of choice for early detection of stress reaction and stress fracture [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/36\">",
"       36",
"      </a>",
"      ]. MRI shows the earliest changes of stress reaction by detecting bone marrow edema before development of the fracture line. MRI is more sensitive than radionuclide bone scan in early detection of bone marrow edema and has high specificity.",
"     </li>",
"     <li>",
"      Radionuclide bone scan &mdash; Radionuclide bone scanning with single photon emission computed tomography (SPECT) is close to 100 percent sensitive in early detection of stress fractures. Positive findings can be seen within 6 to 72 hours of development of stress fracture. Specificity of bone scan is low.",
"     </li>",
"     <li>",
"      CT &mdash; CT has a limited role in diagnosis of stress injuries [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/36\">",
"       36",
"      </a>",
"      ]. CT is more sensitive than plain film radiography for detecting certain stress fractures, but the sensitivity is lower than MRI.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     KNEE TUMORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tumors and tumor-like processes within the knee or in the surrounding bone or soft tissues can cause chronic knee pain. Imaging techniques play an important role in the evaluation of such lesions and, when biopsy or excision is being considered, in the preoperative planning process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     PLICA SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plica syndrome is an uncommon entity caused by a thickened and stiff medial patellar plica trapped between the patella and femur, causing symptoms of pain, locking, and clicking similar to those due to a torn meniscus. The plicae are embryological remnants that may be found in the suprapatellar, infrapatellar and medial compartments of the patellofemoral joint. The suprapatellar and infrapatellar plica do not cause plica syndrome. Features of the plica syndrome identified on magnetic resonance imaging (MRI) are diffusely thickened medial plica, which may be associated with synovitis or erosion of the articular cartilage of the patella or femoral condyle [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     CHONDROMALACIA PATELLAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chondromalacia patellae is a syndrome of patellofemoral pain seen primarily in adolescents and young adults secondary to repeated microtrauma or single traumatic injury to the posterior patellar articular cartilage. Patellofemoral maltracking is a risk factor, resulting in recurrent patellar subluxation and trauma to the patellar cartilage. Although the diagnosis can usually be made clinically, MRI is the modality of choice when chondromalacia patellae is suspected but the diagnosis is uncertain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography &mdash; Plain film radiography is limited in diagnosis of early chondromalacia patellae. In more advanced stages, joint space narrowing and signs of secondary patellofemoral osteoarthritis are seen.",
"     </li>",
"     <li>",
"      MRI &mdash; Reported sensitivity and specificity of MRI for detection of articular cartilage lesions of the patella and femoral trochlea are 91 and 98 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/38\">",
"       38",
"      </a>",
"      ]. MRI shows focal areas of swelling of patellar cartilage, surface irregularity, areas of thinning and areas of cartilage loss with exposure of subchondral bone [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16205273\">",
"    <span class=\"h1\">",
"     DISCOID MENISCUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discoid meniscus is a congenital malformation manifested by abnormal shape and size, having discoid rather than \"C\" shape appearance. It most commonly affects the lateral meniscus and is associated with increased incidence of meniscal degeneration and tear, which can in turn predispose to the development of OA and may contribute to chronic knee pain [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25385/abstract/40\">",
"     40",
"    </a>",
"    ]. MRI diagnoses the abnormal appearance and complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the purposes of this discussion, chronic knee pain has been defined as being present for at least three months.",
"   </p>",
"   <p>",
"    Chronic knee pain is most commonly caused by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Arthritis (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Arthritides'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Bursitis or other cystic lesions (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Bursitis and cysts'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Tendinitis or chronic tears (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Tendon pathology'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Cartilage damage (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Articular cartilage pathology'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Meniscal damage (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Meniscal cartilage pathology'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Chronic infection (see",
"      <a class=\"local\" href=\"#H22\">",
"       'Chronic infection'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Osteonecrosis (see",
"      <a class=\"local\" href=\"#H25\">",
"       'Osteonecrosis (avascular necrosis of bone)'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Stress fractures (see",
"      <a class=\"local\" href=\"#H27\">",
"       'Stress and insufficiency fractures'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Knee tumors (see",
"      <a class=\"local\" href=\"#H28\">",
"       'Knee tumors'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Plica syndrome (see",
"      <a class=\"local\" href=\"#H29\">",
"       'Plica syndrome'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Chondromalacia patellae (see",
"      <a class=\"local\" href=\"#H30\">",
"       'Chondromalacia patellae'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Whether or not radiologic evaluation is necessary for an adult patient with chronic knee pain is a decision that is based on the results of the medical history and physical examination. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=see_link\">",
"     \"Evaluation of the active adult patient with knee pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When radiologic evaluation is indicated, the initial study is generally:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plain film radiography (plain x rays) when arthritis, chronic infection, osteonecrosis, or tumors are suspected or when the cause of chronic knee pain is obscure despite a careful history and physical examination.",
"     </li>",
"     <li>",
"      Ultrasonography when cystic lesions (eg, Baker's cyst, meniscal cyst, etc) are suspected.",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (MRI) when soft tissue pathology is suspected (eg, chronic tendon or meniscal tears, focal articular cartilage damage, or plica syndrome).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Computed tomography (CT)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    CT arthrography may be used in lieu of MRI in patients with contraindications to MRI (eg, pacemakers).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/1\">",
"      Frick MA, Wenger DE, Adkins M. MR imaging of synovial disorders of the knee: an update. Radiol Clin North Am 2007; 45:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/2\">",
"      Fox MG. MR imaging of the meniscus: review, current trends, and clinical implications. Radiol Clin North Am 2007; 45:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/3\">",
"      Epis O, Iagnocco A, Meenagh G, et al. Ultrasound imaging for the rheumatologist. XVI. Ultrasound-guided procedures. Clin Exp Rheumatol 2008; 26:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/4\">",
"      Kijowski R, Blankenbaker DG, Stanton PT, et al. Radiographic findings of osteoarthritis versus arthroscopic findings of articular cartilage degeneration in the tibiofemoral joint. Radiology 2006; 239:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/5\">",
"      Kijowski R, Stanton P, Fine J, De Smet A. Subchondral bone marrow edema in patients with degeneration of the articular cartilage of the knee joint. Radiology 2006; 238:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/6\">",
"      Guermazi A, Niu J, Hayashi D, et al. Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study). BMJ 2012; 345:e5339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/7\">",
"      Conaghan PG, Felson D, Gold G, et al. MRI and non-cartilaginous structures in knee osteoarthritis. Osteoarthritis Cartilage 2006; 14 Suppl A:A87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/8\">",
"      Hayes CW, Jamadar DA, Welch GW, et al. Osteoarthritis of the knee: comparison of MR imaging findings with radiographic severity measurements and pain in middle-aged women. Radiology 2005; 237:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/9\">",
"      Kornaat PR, Bloem JL, Ceulemans RY, et al. Osteoarthritis of the knee: association between clinical features and MR imaging findings. Radiology 2006; 239:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/10\">",
"      Hunter DJ, Zhang Y, Niu J, et al. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006; 54:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/11\">",
"      Felson DT, Niu J, Guermazi A, et al. Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum 2007; 56:2986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/12\">",
"      Ding C, Martel-Pelletier J, Pelletier JP, et al. Meniscal tear as an osteoarthritis risk factor in a largely non-osteoarthritic cohort: a cross-sectional study. J Rheumatol 2007; 34:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/13\">",
"      Englund M, Roos EM, Lohmander LS. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: a sixteen-year followup of meniscectomy with matched controls. Arthritis Rheum 2003; 48:2178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/14\">",
"      Bhattacharyya T, Gale D, Dewire P, et al. The clinical importance of meniscal tears demonstrated by magnetic resonance imaging in osteoarthritis of the knee. J Bone Joint Surg Am 2003; 85-A:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/15\">",
"      Englund M, Guermazi A, Gale D, et al. Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med 2008; 359:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/16\">",
"      Eckstein F, Cicuttini F, Raynauld JP, et al. Magnetic resonance imaging (MRI) of articular cartilage in knee osteoarthritis (OA): morphological assessment. Osteoarthritis Cartilage 2006; 14 Suppl A:A46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/17\">",
"      Raynauld JP, Martel-Pelletier J, Berthiaume MJ, et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum 2004; 50:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/18\">",
"      Cicuttini F, Hankin J, Jones G, Wluka A. Comparison of conventional standing knee radiographs and magnetic resonance imaging in assessing progression of tibiofemoral joint osteoarthritis. Osteoarthritis Cartilage 2005; 13:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/19\">",
"      Brem MH, Pauser J, Yoshioka H, et al. Longitudinal in vivo reproducibility of cartilage volume and surface in osteoarthritis of the knee. Skeletal Radiol 2007; 36:315.",
"     </a>",
"    </li>",
"    <li>",
"     Brower AC. Rheumatoid Arthritis. In: Arthritis in Black and White, 2nd, Brower AC, Flemming DJ (Eds), WB Saunders Company, Philadelphia 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/21\">",
"      Forslind K, Larsson EM, Eberhardt K, et al. Magnetic resonance imaging of the knee: a tool for prediction of joint damage in early rheumatoid arthritis? Scand J Rheumatol 2004; 33:154.",
"     </a>",
"    </li>",
"    <li>",
"     Brower AC. Neuropathic Osteoarthropathy. In: Arthritis in Black and White, 2nd, Brower AC, Flemming DJ (Eds), WB Saunders Company, Philadelphia 1997.",
"    </li>",
"    <li>",
"     Brower AC. Gout. In: Arthritis in Black and White, 2nd, Brower AC, Flemming DJ (Eds), WB Saunders Company, Philadelphia 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/24\">",
"      Gerster JC, Landry M, Dufresne L, Meuwly JY. Imaging of tophaceous gout: computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography. Ann Rheum Dis 2002; 61:52.",
"     </a>",
"    </li>",
"    <li>",
"     Brower AC. Hemophilia. In: Arthritis in Black and White, 2nd, Brower AC, Flemming DJ (Eds), WB Saunders Company, Philadelphia 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/26\">",
"      Krudwig WK, Schulte KK, Heinemann C. Intra-articular ganglion cysts of the knee joint: a report of 85 cases and review of the literature. Knee Surg Sports Traumatol Arthrosc 2004; 12:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/27\">",
"      Beaman FD, Peterson JJ. MR imaging of cysts, ganglia, and bursae about the knee. Radiol Clin North Am 2007; 45:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/28\">",
"      Vande Berg BC, Lecouvet FE, Poilvache P, et al. Assessment of knee cartilage in cadavers with dual-detector spiral CT arthrography and MR imaging. Radiology 2002; 222:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/29\">",
"      Sanghvi DA, Iyer VR, Deshmukh T, Hoskote SS. MRI features of tuberculosis of the knee. Skeletal Radiol 2009; 38:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/30\">",
"      Fayad LM, Carrino JA, Fishman EK. Musculoskeletal infection: role of CT in the emergency department. Radiographics 2007; 27:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/31\">",
"      Lotke PA, Nelson CL, Lonner JH. Spontaneous osteonecrosis of the knee: tibial plateaus. Orthop Clin North Am 2004; 35:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/32\">",
"      Soucacos PN, Johnson EO, Soultanis K, et al. Diagnosis and management of the osteonecrotic triad of the knee. Orthop Clin North Am 2004; 35:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/33\">",
"      Yates PJ, Calder JD, Stranks GJ, et al. Early MRI diagnosis and non-surgical management of spontaneous osteonecrosis of the knee. Knee 2007; 14:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/34\">",
"      Crawford DC, Safran MR. Osteochondritis dissecans of the knee. J Am Acad Orthop Surg 2006; 14:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/35\">",
"      Spitz DJ, Newberg AH. Imaging of stress fractures in the athlete. Radiol Clin North Am 2002; 40:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/36\">",
"      Gaeta M, Minutoli F, Scribano E, et al. CT and MR imaging findings in athletes with early tibial stress injuries: comparison with bone scintigraphy findings and emphasis on cortical abnormalities. Radiology 2005; 235:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/37\">",
"      Garc&iacute;a-Valtuille R, Abascal F, Cerezal L, et al. Anatomy and MR imaging appearances of synovial plicae of the knee. Radiographics 2002; 22:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/38\">",
"      Mohr A. The value of water-excitation 3D FLASH and fat-saturated PDw TSE MR imaging for detecting and grading articular cartilage lesions of the knee. Skeletal Radiol 2003; 32:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/39\">",
"      Yulish BS, Montanez J, Goodfellow DB, et al. Chondromalacia patellae: assessment with MR imaging. Radiology 1987; 164:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25385/abstract/40\">",
"      Rao SK, Sripathi Rao P. Clinical, radiologic and arthroscopic assessment and treatment of bilateral discoid lateral meniscus. Knee Surg Sports Traumatol Arthrosc 2007; 15:597.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1813 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-77.94.48.4-442DE206A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25385=[""].join("\n");
var outline_f24_50_25385=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ARTHRITIDES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Calcium pyrophosphate deposition disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Psoriatic arthritis and reactive arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ankylosing spondylitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Neuropathic arthropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Gouty arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Hemophilic arthropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      BURSITIS AND CYSTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Bursitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Popliteal bursitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Prepatellar bursitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Pes anserinus bursitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cysts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Ganglion cyst",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Meniscal cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      TENDON PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ARTICULAR CARTILAGE PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      MENISCAL CARTILAGE PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      CHRONIC INFECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Chronic infectious arthritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Chronic osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      OSTEONECROSIS (AVASCULAR NECROSIS OF BONE)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Osteochondritis dissecans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      STRESS AND INSUFFICIENCY FRACTURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      KNEE TUMORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      PLICA SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      CHONDROMALACIA PATELLAE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16205273\">",
"      DISCOID MENISCUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/1813\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/1813|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/36/40527\" title=\"diagnostic image 1\">",
"      Knee OA AP x ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/3/35902\" title=\"diagnostic image 2\">",
"      Chondrocalcin knee x ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/41/28304\" title=\"diagnostic image 3\">",
"      Baker cyst MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?40/58/41888\" title=\"diagnostic image 4\">",
"      Bakers cyst sonogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/11/23743\" title=\"diagnostic image 5\">",
"      Prepatellar bursitis MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/37/18000\" title=\"diagnostic image 6\">",
"      Norm ad sagital knee MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/54/21345\" title=\"diagnostic image 7\">",
"      Part patella tendon tear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?26/11/26800\" title=\"diagnostic image 8\">",
"      Full thick quad tear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/4/14415\" title=\"diagnostic image 9\">",
"      Oblique med meniscus tear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?22/44/23232\" title=\"diagnostic image 10\">",
"      Osteochondral knee fract",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/1813|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/27/35251\" title=\"figure 1\">",
"      Anterior anatomy of knee",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/10/42150?source=related_link\">",
"      Antineoplastic therapy for miscellaneous benign diseases affecting soft tissue and bone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12071?source=related_link\">",
"      Approach to imaging modalities in the setting of suspected osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5273?source=related_link\">",
"      Approach to the young athlete with acute knee pain or injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/34/29223?source=related_link\">",
"      Approach to the young athlete with chronic knee pain or injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/25/11671?source=related_link\">",
"      Candida osteoarticular infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/38/7785?source=related_link\">",
"      Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4890?source=related_link\">",
"      Clinical manifestations and diagnosis of gout",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/18/1322?source=related_link\">",
"      Clinical manifestations and diagnosis of hemophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13913?source=related_link\">",
"      Clinical manifestations and diagnosis of osteochondritis dissecans (OCD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/49/30488?source=related_link\">",
"      Clinical manifestations and diagnosis of psoriatic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/32/33287?source=related_link\">",
"      Diagnosis and classification of osteoarthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=related_link\">",
"      Diagnosis and differential diagnosis of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6010?source=related_link\">",
"      Diagnosis and differential diagnosis of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/12/33994?source=related_link\">",
"      Diagnosis of suspected deep vein thrombosis of the lower extremity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/7/3193?source=related_link\">",
"      Diagnostic imaging of joint pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/29/6618?source=related_link\">",
"      Evaluation of the active adult patient with knee pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39098?source=related_link\">",
"      General principles of management of rheumatoid arthritis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/48/28422?source=related_link\">",
"      Knee bursitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19014?source=related_link\">",
"      Management of osteochondritis dissecans (OCD)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26807?source=related_link\">",
"      Manifestations and treatment of extrapulmonary coccidioidomycosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/15/16632?source=related_link\">",
"      Meniscal injury of the knee",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/43/28346?source=related_link\">",
"      Osteonecrosis (avascular necrosis of bone)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/19/23866?source=related_link\">",
"      Overview of stress fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/24/27016?source=related_link\">",
"      Popliteal (Baker's) cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/12/12489?source=related_link\">",
"      Radiologic evaluation of the acutely painful knee in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/27/33210?source=related_link\">",
"      Reactive arthritis (formerly Reiter syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/49/37656?source=related_link\">",
"      Skeletal tuberculosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_50_25386="Primary angiitis of the central nervous system";
var content_f24_50_25386=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Primary angiitis of the central nervous system",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Rula Hajj-Ali, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Leonard H Calabrese, DO",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Gene G Hunder, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/50/25386/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/50/25386/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angiitis of the central nervous system (CNS) may arise from primary involvement of blood vessels in the brain or spinal cord, or from secondary involvement of the CNS by a systemic disorder such as systemic vasculitis, a connective tissue disease, or an infectious process [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Angiitis, a synonym for vasculitis, refers generally to blood vessels on both the arterial and venous sides of the circulation. The preferred name for angiitis that is confined to the brain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    spinal cord is primary angiitis of the central nervous system (PACNS). Other names for PACNS include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated CNS vasculitis",
"     </li>",
"     <li>",
"      Primary CNS vasculitis",
"     </li>",
"     <li>",
"      Granulomatous angiitis of the nervous system",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PACNS may affect small- and medium-sized cerebral blood vessels over diffuse areas of the CNS. Secondary CNS vasculitis is the term used if the inflammatory process affecting the CNS is a part of a systemic process, such as an infectious or inflammatory disorder.",
"   </p>",
"   <p>",
"    The protean manifestations of PACNS, along with the nonspecificity of available diagnostic modalities, pose a challenge for accurate diagnosis. Clinicians caring for patients with suspected PACNS should be familiar with its mimics to avoid misdiagnosis. PACNS can be mimicked closely in both its clinical presentation and radiologic manifestations by a number of disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/3\">",
"     3",
"    </a>",
"    ]. The most frequent mimic of PACNS is a group of disorders known collectively as the reversible cerebral vasoconstriction syndromes (RCVS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link&amp;anchor=H13#H13\">",
"     \"Thunderclap headache\", section on 'Reversible cerebral vasoconstriction syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical characteristics, diagnosis, and treatment of PACNS will be reviewed here. PACNS in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40616?source=see_link&amp;anchor=H18#H18\">",
"     \"Classification and incidence of childhood vasculitis\", section on 'Primary angiitis of the CNS'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;PACNS affects small- and medium-sized arteries of the brain parenchyma, spinal cord, and leptomeninges, resulting in symptoms and signs of CNS dysfunction. It is defined by inflammation of the cerebral vasculature without angiitis in other organs.",
"   </p>",
"   <p>",
"    PACNS, initially termed isolated central nervous system vasculitis, was first proposed as a separate disease entity in 1959. Multiple case series and reviews have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Sorting through the literature on PACNS is complex, because studies have used variable case definitions of CNS vasculitis and often included patients whose disorders were nonvasculitic in nature.",
"   </p>",
"   <p>",
"    Better recognition arose in 1993 that cases previously reported as PACNS encompassed a mixture of different subsets that behaved differently clinically and prognostically [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/7\">",
"     7",
"    </a>",
"    ]. At that time, in a review of 108 patients from the English language literature and the Cleveland Clinic experience, if was found that many patients labeled as having PACNS, based upon angiographic findings, had different clinical and radiographic features from those diagnosed on a histopathologic basis. A category of patients was recognized who presented mainly with acute onset of headaches, and were characterized by normal cerebral spinal fluid (CSF) studies but highly abnormal cerebral angiograms. These patients had a monophasic course without recurrence. Thus, the term \"benign angiopathy of the central nervous system\" (BACNS) was selected to describe them.",
"   </p>",
"   <p>",
"    Subsequently, other related syndromes were also identified with the same clinical and radiological phenotype characteristics of BACNS. Currently, RCVS is the term used for these syndromes. Many published PACNS series and case reports have not distinguished patients now recognized as having RCVS from those with true PACNS, which has created challenges in analyzing the literature. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Reversible cerebral vasoconstriction syndromes'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    PACNS poses difficult challenges in diagnosis for a number of reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The disorder is rare.",
"     </li>",
"     <li>",
"      The risk factors are poorly defined.",
"     </li>",
"     <li>",
"      The symptoms and signs may also be caused by a variety of nonvasculitic conditions.",
"     </li>",
"     <li>",
"      Diagnostic test results often yield nonspecific abnormalities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pathologic findings in the brain in patients with PACNS include the presence of Langerhans or foreign body giant cells, necrotizing vasculitis, or lymphocytic vasculitis. PACNS is referred to as granulomatous angiitis of the CNS (GACNS), if the pathologic findings are those of granulomatous angiitis affecting the small and medium leptomeningeal and cortical arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/5\">",
"     5",
"    </a>",
"    ]. However, the classic finding of granulomatous segmental vasculitis with Langerhans or foreign body giant cells is present in less that 50 percent of the biopsies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/8\">",
"     8",
"    </a>",
"    ]. The biopsy is not granulomatous in most such cases, and only reveals lymphocytic vasculitis. We have referred to these cases as \"atypical PACNS\" as they diverge pathologically from the classic pathologic findings in GACNS; this classification has also been accepted by other vasculitis specialists. A thorough investigation should be performed on the available brain tissue in such patients to exclude any infectious or malignant process. The findings of vasculitis on pathology do not exclude an associated infection or malignancy.",
"   </p>",
"   <p>",
"    Patients diagnosed by cerebral angiography and magnetic resonance imaging (MRI), with the exclusion of mimics, but without biopsy confirmation of the diagnosis, are also included in the atypical PACNS category. The CSF analysis in these patients is usually abnormal and does not preclude the diagnosis of RCVS.",
"   </p>",
"   <p>",
"    The inflammation of the CNS causes the vessels to become narrowed, occluded and thrombosed, resulting in tissue ischemia and necrosis of the territories of the involved vessels. Skipped lesions are common. Because of the focal and segmental distribution of CNS vasculitis, a positive biopsy is diagnostic, but a single isolated negative biopsy does not exclude primary or secondary CNS vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/8\">",
"     8",
"    </a>",
"    ]. Appropriate stains, viral studies and cultures should be performed on the biopsies since the finding of vasculitis does not preclude the diagnosis of an associated infection or a lymphoproliferative process that is causing the vasculitis.",
"   </p>",
"   <p>",
"    PACNS is more likely to affect blood vessels in the cerebral cortex and leptomeninges than subcortical regions. Blood vessels supplying cranial nerves may also be involved. In contrast to systemic vasculitides, the finding of aneurysms in the cerebral arteries is rare, and if present should raise the suspicion of septic inflammatory process.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of PACNS is unknown. Studies are complicated by the rarity of the condition and by difficulties in obtaining adequate quantities of diseased tissue from patients. Several potential etiologic agents or mechanisms have been proposed, but understanding of the cause of PACNS remains highly speculative.",
"   </p>",
"   <p>",
"    It is likely that PACNS has multiple causes. It is also possible if not probable that when PACNS is understood more completely, a variety of different diseases will be discerned within what is viewed presently as a monolithic disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infectious agents, particularly mycoplasma and viruses, have been proposed as etiologic factors in PACNS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An angiitis similar to PACNS has been produced in turkeys inoculated with Mycoplasma gallisepticum [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Central nervous system vasculitis has been reported as a complication of varicella zoster virus, West Nile virus, and other viruses [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21288?source=see_link\">",
"       \"Stroke caused by varicella zoster virus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Speculation has surrounded the potential role of retroviruses in the etiology of PACNS [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/13\">",
"       13",
"      </a>",
"      ]. HIV infection can cause both a CNS vasculitis and a CNS vasculopathy that is associated with aneurysm formation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/14,15\">",
"       14,15",
"      </a>",
"      ]. CNS vasculitis has also been reported in the setting of the immune reconstitution syndrome among patients with AIDS [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Amyloid angiopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral amyloid angiopathy and PACNS have been described together in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/17-23\">",
"     17-23",
"    </a>",
"    ]. The histopathology of brain lesions in such patients includes angiodestructive inflammation (ie, evidence of vasculitis) that is often granulomatous, lymphocytic infiltration of the meninges, and amyloidogenic A-beta protein in cytoplasmic inclusions and in vessel walls. This combination of two rare disorders probably occurs more frequently than would be expected by chance alone [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37001?source=see_link&amp;anchor=H11#H11\">",
"     \"Cerebral amyloid angiopathy\", section on 'Perivascular/vascular inflammation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the possibility that infection, amyloid angiopathy, and other factors contribute to some cases of PACNS, most cases have no such potential causes identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;PACNS appears to be male predominant and occurs at any age. There is a 2:1 male predominance among reported cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1\">",
"     1",
"    </a>",
"    ]. The mean age at diagnosis is 42 years, with a range from 3 to 78 years. PACNS is characterized by a long prodromal period, with few patients presenting acutely. Signs and symptoms of systemic vasculitis, such as peripheral neuropathy, fever, weight loss, or rash, are usually lacking.",
"   </p>",
"   <p>",
"    The vasculitis affects any part of the CNS, causing the clinical manifestations to be highly variable and nonspecific [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1\">",
"     1",
"    </a>",
"    ]. PACNS should be suspected when strokes, more often recurrent, occur in young patients with no identifiable cardiovascular or hypercoagulable risk factors, or in the setting of chronic meningitis, recurrent focal neurologic symptoms, unexplained diffuse neurologic dysfunction, or unexplained spinal cord dysfunction not associated with systemic disease or any other process.",
"   </p>",
"   <p>",
"    In a series of 116 patients with pathologically-confirmed disease, nearly 70 percent of patients presented with diffuse neurologic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1\">",
"     1",
"    </a>",
"    ]. The neurologic symptoms included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Decreased cognition &mdash; 83 percent",
"     </li>",
"     <li>",
"      Headache &mdash; 56 percent",
"     </li>",
"     <li>",
"      Seizure &mdash; 30 percent",
"     </li>",
"     <li>",
"      Stroke &mdash; 14 percent",
"     </li>",
"     <li>",
"      Cerebral hemorrhage &mdash; 12 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Spinal cord involvement occurs alone or coincides with parenchymal brain involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/25\">",
"     25",
"    </a>",
"    ]. Angiitis affecting the spinal cord usually presents as a myelopathy, with pain, motor weakness, and sensory findings. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=see_link&amp;anchor=H16#H16\">",
"     \"Disorders affecting the spinal cord\", section on 'Spinal cord infarction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms and signs of untreated PACNS progress over the course of months. In the series described above, the mean time from symptom onset to diagnosis was 170 days. This is in important contrast to the reversible cerebral vasoconstriction syndromes, which typically have a more acute onset and much shorter time to diagnosis. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Reversible cerebral vasoconstriction syndromes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory testing, serological evaluations, lumbar puncture results, neuroimaging studies, cerebral angiography, and brain biopsy may all have roles in the evaluation of patients with possible PACNS. However, there is no specific test for the diagnosis of PACNS; the diagnostic modalities should be interpreted in conjunction with each other.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute phase reactants such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are usually normal in PACNS. An elevated ESR and CRP should raise suspicion of systemic involvement by either an infectious or inflammatory process.",
"   </p>",
"   <p>",
"    Both serologic evaluations and analyses of the cerebrospinal fluid (CSF) are important in excluding secondary causes of CNS dysfunction that may mimic PACNS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Serologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following serologic evaluation is appropriate in patients suspected of PACNS. The major point of serologic assays is to exclude underlying connective tissue disorders.",
"   </p>",
"   <p>",
"    Basic laboratory testing should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count with differential",
"     </li>",
"     <li>",
"      Serum urea nitrogen and creatinine",
"     </li>",
"     <li>",
"      Serum aspartate and alanine aminotransferases",
"     </li>",
"     <li>",
"      ESR and C-reactive protein",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specialized laboratory testing should include assays for:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Antinuclear antibodies",
"     </li>",
"     <li>",
"      Rheumatoid factor",
"     </li>",
"     <li>",
"      Antibodies to the",
"      <span class=\"nowrap\">",
"       Ro/SSA,",
"      </span>",
"      <span class=\"nowrap\">",
"       La/SSB,",
"      </span>",
"      Sm, and RNP antigens",
"     </li>",
"     <li>",
"      Antibodies to double-stranded DNA",
"     </li>",
"     <li>",
"      Antineutrophil cytoplasmic antibodies (ANCA)",
"     </li>",
"     <li>",
"      Serum C3 and C4",
"     </li>",
"     <li>",
"      Serum cryoglobulins",
"     </li>",
"     <li>",
"      Serum and urine protein electrophoresis with immune electrophoresis",
"     </li>",
"     <li>",
"      Quantitative immunoglobulin levels (IgG, IgM, IgA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testing for infections appropriate to the clinical circumstances is critical, as the treatment for infectious causes of CNS dysfunction differs radically from the therapy for immune-mediated disorders. A thorough history for any risk factors for immunodeficiency as well as travel history is important in the assessment for any exposure or an immunodeficiency state. In addition to cultures of the blood, CSF, and other body fluids, diagnostic tests for infection may include assays for the following organisms.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Treponema pallidum",
"     </li>",
"     <li>",
"      Borrelia burgdorferi",
"     </li>",
"     <li>",
"      Bartonella species",
"     </li>",
"     <li>",
"      Mycobacterium tuberculosis",
"     </li>",
"     <li>",
"      Herpesviruses (varicella-zoster virus, cytomegalovirus, others)",
"     </li>",
"     <li>",
"      Hepatitis B and C viruses",
"     </li>",
"     <li>",
"      HIV",
"     </li>",
"     <li>",
"      Cysticercosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Analysis of the cerebrospinal fluid (CSF) is a crucial part of the evaluation of patients with potential PACNS. CSF is abnormal in 80 to 90 percent of patients with pathologically documented disease. There are no specific abnormalities of the CSF in PACNS. The importance of CSF analysis in excluding any infectious or malignant process and the performance of adequate stains and cultures of the CSF cannot be overemphasized. In RCVS, the most common mimic of PACNS, the CSF analysis is usually normal or reflects findings of subarachnoid hemorrhage if this is present [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various neuroimaging modalities have been used in the evaluation of possible PACNS. The gold standard for the detection of narrowing and other abnormalities of the vascular lumen remains angiography. However, magnetic resonance (MR) imaging studies serve as an important complement to angiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic cerebral angiography studies in PACNS reveal findings of ectasia and stenosis referred to as \"beading\", usually in the small arteries. Involvement of several sites of the cerebral circulation is typical of PACNS. Other findings include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Circumferential or eccentric vessel irregularities",
"     </li>",
"     <li>",
"      Multiple occlusions with sharp cutoffs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In unusual cases of PACNS, the disease presents radiologically as a CNS mass lesion, manifested on angiography by the presence of an avascular mass effect (",
"    <a class=\"graphic graphic_picture graphicRef52006 \" href=\"UTD.htm?15/58/16292\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Proper interpretation of CNS angiograms requires insight into the clinical context of the specific patient, experience in reading abnormal angiograms, and thorough appreciation of the range of normal findings within the circulation of the internal carotid artery and its intracerebral branches (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63788 \" href=\"UTD.htm?10/62/11234\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A common concern is that angiography in a patient with possible cerebral vessel inflammation may result in stroke or other complications. This view appears to be unfounded. In one study of 125 consecutive cerebral angiograms performed to exclude vasculitis of the CNS, there was no increased risk of procedural complications among the 16 patients with CNS vasculitis compared to those without CNS vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In performing angiography for the evaluation of potential PACNS, it is essential to bear in mind two points:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The sensitivity of angiography is rather poor, because PACNS often involves blood vessels below the resolution of conventional angiography. In two series of patients with PACNS, the sensitivity of angiography in biopsy proven PACNS cases was only 60 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/28,29\">",
"       28,29",
"      </a>",
"      ]. Thus, a negative angiogram cannot be used to exclude the diagnosis of PACNS.",
"     </li>",
"     <li>",
"      No single angiographic feature or combination of features is diagnostic of PACNS. PACNS has a host of potential mimickers of its angiographic features. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Differential diagnosis'",
"      </a>",
"      below.) In addition, angiographic findings interpreted as \"consistent with vasculitis\" greatly outnumber true cases of PACNS. Thus, a positive angiogram does not make the diagnosis of PACNS. In a study of 38 patients with suspected PACNS, 14 patients had typical angiographic findings of vasculitis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/30\">",
"       30",
"      </a>",
"      ]. None were found to have vasculitic changes at brain biopsy. This study reflects the poor specificity of the angiographic findings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Normal biopsy specimens may reflect either a patchy distribution of inflammation (ie, sampling error) or true negative results, reflecting the poor specificity of cerebral angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1,31\">",
"     1,31",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Reversible cerebral vasoconstriction syndromes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Repeat angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although it is not common to perform serial angiograms as a way of following response to treatment, repeat angiography is sometimes useful if the diagnosis remains unclear days to weeks after the performance of an initial study. A rapid change in angiographic appearance (eg, evolution from a flagrantly abnormal study to one that is essentially normal within days or weeks) argues compellingly for a reversible cerebral vasoconstriction syndrome rather than PACNS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/31\">",
"     31",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_diagnosticimage graphicRef66139 \" href=\"UTD.htm?37/8/38017\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     MR imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral lesions on magnetic resonance (MR) imaging studies in PACNS may be single or multiple, may include infarcts (both white and gray matter) and hemorrhage, and may be tumor-like [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/17,32,33\">",
"     17,32,33",
"    </a>",
"    ]. The MRI findings of vascular involvement of the CNS associated with systemic diseases were recently reviewed in 24 patients (17 women and 7 men), with a diagnosis of secondary CNS vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/34\">",
"     34",
"    </a>",
"    ]. Underlying causes for CNS vasculitis included systemic lupus erythematosus, tuberculosis, bacterial meningitis, Takayasu arteritis, polyarteritis nodosa, syphilis, drug abuse, yellow fever and varicella. Nonspecific high-intensity",
"    <span class=\"nowrap\">",
"     T2WI/FLAIR",
"    </span>",
"    lesions in white matter were the most common finding, and were present in 42 percent of patients. Thirty-three percent had infarctions in large cerebral arteries territory, associated or not with high-intensity",
"    <span class=\"nowrap\">",
"     T2WI/FLAIR",
"    </span>",
"    small foci.",
"   </p>",
"   <p>",
"    The finding of T2-hyperintense foci on MRI can pose serious diagnostic problems, because of their low specificity, and should be interpreted carefully in the context of other clinical data and diagnostic tests. MRI findings of T2-hyperintense foci can be associated with widened perivascular spaces, brain aging, migraine, ischemic changes, hypoxic-ischemic changes, hemorrhagic foci, inflammatory changes, multiple sclerosis, central pontine and extrapontine myelinolysis, metastases, changes caused by radio- and chemotherapy, lesions associated with neurometabolic diseases, CNS degenerative diseases, and eclampsia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/35\">",
"     35",
"    </a>",
"    ]. The interpretation of the MRI findings should be performed by an expert neuroradiologist who is familiar with the findings of CNS vasculitis and its radiologic mimics.",
"   </p>",
"   <p>",
"    MR imaging is not as sensitive as conventional angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1,17,28,29,36-38\">",
"     1,17,28,29,36-38",
"    </a>",
"    ]. As an example, one study of seven patients with PACNS found that MRI changes usually correlated with those observed with the angiogram; however, no lesions were found by MR in 12 of 33 vessels determined to be abnormal by angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     MR angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The resolution of MR angiography (MRA) remains inadequate for the demonstration of vasculitic changes in any blood vessels smaller than the major intracranial arteries or their primary branches. Thus, MRA studies are generally of little use in the evaluation of PACNS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Brain and leptomeningeal biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for the diagnosis of PACNS is histopathology. Sampling of the leptomeninges as well as the underlying cortex increases the diagnostic yield. However, the test characteristics of brain biopsy are far from optimal. In one case series, premortem biopsies yielded false-negative results in 25 percent of autopsied cases [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/28\">",
"     28",
"    </a>",
"    ]. While this is suboptimal, brain biopsies are important in excluding disorders that mimic vasculitis (see",
"    <a class=\"local\" href=\"#H29\">",
"     'Selecting patients for brain biopsy'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Biopsy of a radiologically abnormal area heightens the sensitivity of",
"    <span class=\"nowrap\">",
"     brain/leptomeningeal",
"    </span>",
"    biopsies. In the absence of a focal lesion within the brain parenchyma, the temporal tip of the nondominant hemisphere is the preferred biopsy site [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinician must remember that when PACNS is the potential diagnosis, the correct diagnosis is usually something else. As a result, careful exclusion of other disorders is essential. Because of the importance of eliminating a lengthy list of alternative diagnoses, the differential diagnosis of PACNS is discussed in detail before reviewing a suggested approach to diagnosis.",
"   </p>",
"   <p>",
"    The major categories of disease in the differential diagnosis of PACNS are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Reversible cerebral vasoconstriction syndromes",
"     </li>",
"     <li>",
"      Systemic vasculitis involving the brain",
"     </li>",
"     <li>",
"      Connective tissue diseases",
"     </li>",
"     <li>",
"      Infections",
"     </li>",
"     <li>",
"      Atherosclerosis",
"     </li>",
"     <li>",
"      Embolic disease",
"     </li>",
"     <li>",
"      Malignancy",
"     </li>",
"     <li>",
"      Miscellaneous conditions",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Reversible cerebral vasoconstriction syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reversible cerebral vasoconstriction syndromes (RCVS) are a group of disorders linked by prolonged but reversible vasoconstriction of the cerebral arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/31\">",
"     31",
"    </a>",
"    ]. The RCVS are typically associated with severe, acute-onset headaches that can recur intermittently for days to weeks, sometimes accompanied by neurologic symptoms and signs. The headaches associated with the RCVS are usually \"thunderclap\" in nature.",
"   </p>",
"   <p>",
"    Ischemic stroke",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hemorrhage associated with reperfusion may occur in the setting of RCVS. Thus, despite the reversibility of vasoconstriction, these disorders are not always characterized by benign prognoses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link&amp;anchor=H13#H13\">",
"     \"Thunderclap headache\", section on 'Reversible cerebral vasoconstriction syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    RCVS has been described by a number of different terms and in a number of different settings, which include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Benign angiopathy of the CNS",
"     </li>",
"     <li>",
"      Drug-induced vasculopathy",
"     </li>",
"     <li>",
"      Postpartum angiopathy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24458?source=see_link&amp;anchor=H6#H6\">",
"       \"Cerebrovascular disorders complicating pregnancy\", section on 'Postpartum angiopathy'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Migrainous vasospasm (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32953?source=see_link&amp;anchor=H22#H22\">",
"       \"Headache, migraine, and stroke\", section on 'Mechanisms'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Thunderclap headache (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=see_link\">",
"       \"Thunderclap headache\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The Call syndrome (or the Call-Fleming syndrome)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to these syndromes, pheochromocytoma and poorly-controlled hypertension can also be associated with cerebral vasospasm and clinical presentations that mimic PACNS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=see_link\">",
"     \"Clinical presentation and diagnosis of pheochromocytoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These syndromes overlap substantially with each other and with PACNS in their clinical features and are indistinguishable by radiologic studies. In differentiating the RCVS from PACNS, there are four essential considerations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The acuity of symptom onset &mdash; RCVS typically begin abruptly, in contrast to the subacute onset of PACNS.",
"     </li>",
"     <li>",
"      Clinical setting &mdash; RCVS frequently occur in defined clinical settings such as in the postpartum period, in the context of a migraine headache, or following the ingestion of vasoactive medications such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"       pseudoephedrine",
"      </a>",
"      , while PACNS has none of these associations. However, RCVS can present without identifiable associations or triggers, thus posing a diagnostic challenge. RCVS typically present in women, while occurrence in men is more common in PACNS.",
"     </li>",
"     <li>",
"      Reversibility of angiographic findings &mdash; The angiographic changes of RCVS are readily reversible within days to weeks. The crucial diagnostic test is often the performance of a second cerebral angiogram at an appropriate interval, usually some weeks after the angiogram that demonstrated findings concerning for possible PACNS. When \"CNS vasculitis\" resolves spontaneously or with only a short period of glucocorticoid therapy, a form of RCVS is the probable explanation.",
"     </li>",
"     <li>",
"      Cerebral spinal fluid (CSF) findings are usually normal in RCVS, unless there is an associated subarachnoid hemorrhage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although it is important to differentiate between RCVS and PACNS, given the different therapeutic implications, it is not uncommon in clinical practice to mistakenly diagnose CNS vasculitis in patients with RCVS. Patients in whom PACNS is suspected during the initial presentation are often treated with immunosuppressive therapy, which is discontinued if the second angiogram is consistent with a form of RCVS. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Initial therapy of suspected PACNS'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Systemic vasculitis involving the brain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some forms of vasculitis can involve the CNS. The ones most likely to do so are the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beh&ccedil;et's disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/18/298?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease\", section on 'Neurologic disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Polyarteritis nodosa. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations and diagnosis of polyarteritis nodosa\", section on 'Neurologic disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vasculitides associated with antineutrophil cytoplasmic antibodies, including granulomatosis with polyangiitis (Wegener&rsquo;s), microscopic polyangiitis, and Churg-Strauss syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link\">",
"       \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21383?source=see_link\">",
"       \"Epidemiology, pathogenesis, and pathology of Churg-Strauss syndrome (allergic granulomatosis and angiitis)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cryoglobulinemic vasculitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=see_link\">",
"       \"Overview of cryoglobulins and cryoglobulinemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of CNS vasculitis secondary to a systemic form of vasculitis is usually inferred from biopsy or angiography of a non-CNS site. In most such patients, the systemic vasculitis is an established diagnosis before the CNS is involved. We assign high importance to performing a thorough evaluation to exclude an infectious etiology of the CNS process, given the immunosuppressive treatments that patients are usually receiving for their systemic vasculitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Connective tissue diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;CNS manifestations due to other connective tissue diseases may reflect vasculitis or other mechanisms and can occur with or without systemic symptoms. In this setting, diagnosis of the underlying diseases is frequently based upon vasculitic or non-vasculitic clinical features in organs outside the CNS, combined with selected laboratory results.",
"   </p>",
"   <p>",
"    The connective tissue diseases most likely to involve the CNS and create confusion with the diagnosis of PACNS are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      SLE and related conditions &mdash; SLE, Sj&ouml;gren's syndrome, mixed connective tissue disease, and dermatomyositis can all be associated with CNS involvement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5816?source=see_link\">",
"       \"Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link\">",
"       \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43401?source=see_link\">",
"       \"Clinical manifestations of mixed connective tissue disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=see_link\">",
"       \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Pathologic abnormalities in neuropsychiatric lupus include multifocal microinfarcts, cortical atrophy, gross infarcts, hemorrhage, ischemic demyelination, and patchy multiple sclerosis-like demyelination. The most common microscopic brain finding in SLE is microvasculopathy, described as \"healed vasculitis\" consistent with hyalinization, thickening, and thrombus formation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/40-42\">",
"       40-42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nonvasculitic autoimmune inflammatory meningoencephalitis &mdash; Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM) is a syndrome characterized clinically by dementia that occurs in some patients with this disorder at a younger age of onset, rapid progression with significant cognitive and behavioral features, absence of family history, abnormal EEG findings, and elevated levels of inflammatory markers [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/43\">",
"       43",
"      </a>",
"      ]. The CNS involvement that may be seen in Hashimoto thyroiditis is considered as a form of NAIM. The pathologic findings of NAIM are those of a panencephalitis without evidence of a vasculitis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/43\">",
"       43",
"      </a>",
"      ]. Patients with NAIM are usually successfully treated with glucocorticoids.",
"     </li>",
"     <li>",
"      Rheumatoid arthritis &mdash; Rheumatoid vasculitis occasionally involves the CNS. However, the most common neurologic manifestation of rheumatoid vasculitis is vasculitic neuropathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link\">",
"       \"Clinical manifestations and diagnosis of rheumatoid vasculitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antiphospholipid syndrome &mdash; The antiphospholipid syndrome can cause CNS dysfunction due to strokes caused by intracerebral clotting events, emboli associated with verrucous endocarditis, or white matter lesions suggestive of a vasculopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=see_link\">",
"       \"Clinical manifestations of the antiphospholipid syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Many but not all cases of the Sneddon syndrome, the combination of livedo reticularis and cerebrovascular lesions, are associated with antiphospholipid antibodies. However, the Sneddon syndrome is unlikely to be confused with PACNS if the livedo reticularis is appreciated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of bacterial, mycobacterial, viral, fungal, and rickettsial infections can mimic PACNS. Prompt culture of all potential sites of infection, including the CSF, is therefore essential.",
"   </p>",
"   <p>",
"    Organisms that cause subacute or chronic infections are the ones most likely to imitate PACNS. The major organisms of concern are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treponema pallidum (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/44/26312?source=see_link\">",
"       \"Neurosyphilis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Borrelia burgdorferi (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=see_link\">",
"       \"Clinical manifestations of Lyme disease in adults\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Bartonella species (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=see_link&amp;anchor=H2#H2\">",
"       \"Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients\", section on 'Bacillary angiomatosis'",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Mycobacterium tuberculosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=see_link\">",
"       \"Central nervous system tuberculosis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Herpesviruses such as varicella-zoster virus and cytomegalovirus (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21288?source=see_link\">",
"       \"Stroke caused by varicella zoster virus\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Hepatitis B and C viruses, which can be associated with polyarteritis nodosa and mixed cryoglobulinemia, respectively (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=see_link\">",
"       \"Clinical manifestations and diagnosis of polyarteritis nodosa\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=see_link\">",
"       \"Overview of cryoglobulins and cryoglobulinemia\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      HIV infection (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41128?source=see_link\">",
"       \"Approach to HIV-infected patients with central nervous system lesions\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Fungi such as Aspergillus, Coccidioides, and Histoplasma species (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38104?source=see_link\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of brain abscess\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Cysticercosis can involve middle-size cerebral vessels of the subarachnoid space, often without clinical evidence of cerebral ischemia [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/44\">",
"       44",
"      </a>",
"      ]. Cysticercosis is endemic in many regions of Central and South America, sub-Saharan Africa, India, and Asia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=see_link\">",
"       \"Clinical manifestations and diagnosis of cysticercosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Atherosclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerosis of intracranial vessels can mimic the angiographic findings of PACNS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1,4\">",
"     1,4",
"    </a>",
"    ]. Because common things are common, the patient with multiple atherosclerotic risk factors and CNS dysfunction such as evidence of a cerebrovascular accident is much more likely to have atherosclerosis than PACNS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Cerebral emboli",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cerebral emboli can result in multifocal vascular occlusions that suggest the diagnosis of vasculitis. As many as 30 to 40 percent of ischemic strokes remain cryptogenic despite the availability of transesophageal echocardiography, carotid ultrasonography, and MR angiography to help identify embolic sources. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/10/40105?source=see_link\">",
"     \"Cryptogenic stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=see_link&amp;anchor=H29#H29\">",
"     \"Overview of the evaluation of stroke\", section on 'Embolic stroke'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of types of embolic events can create confusion with PACNS. These include atrial fibrillation, from paradoxical emboli in patients with venous thromboemboli and a patent foramen ovale, atrial myxoma, and from marantic endocarditis.",
"   </p>",
"   <p>",
"    Atheroemboli are another cause of embolic stroke that may be confused with PACNS. Atheroemboli are often released from vessels other than the carotid arteries (especially the aorta), with a predilection for the middle cerebral artery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/45\">",
"     45",
"    </a>",
"    ]. Systemic signs of atheroembolism (eg, livedo reticularis, acute renal failure), if present, would exclude PACNS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31994?source=see_link\">",
"     \"Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Intravascular lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravascular lymphoma that leads to widespread occlusion of small vessels is an occasional mimicker of PACNS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Appropriate immunohistochemistry staining as well as B and T cell markers should be performed on biopsy specimens even with the pathologic finding of angiitis, since the presence of vasculitic changes does not exclude an underlying lymphoproliferative condition. Lymph node, bone marrow, and CSF involvement may not be evident at presentation, as delays of up to five years have been reported before the emergence of extracranial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13511?source=see_link\">",
"     \"Intravascular large cell lymphoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Miscellaneous",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other diseases that can mimic PACNS include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral artery dissection &mdash; Cervical internal carotid artery dissection occasionally presents with headache and scintillating scotomata in the ipsilateral visual field. Many patients with carotid or vertebral artery dissections progress to cerebral ischemia. The combination of headache followed by stroke mimics PACNS. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32953?source=see_link\">",
"       \"Headache, migraine, and stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sarcoidosis &mdash; Approximately 5 percent of patients with sarcoidosis develop clinically evident neurological involvement. In a manner similar to PACNS, sarcoidosis can be associated with granulomatous brain masses, encephalopathy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      meningeal disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/8/20616?source=see_link\">",
"       \"Neurologic sarcoidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Susac syndrome &mdash; Susac syndrome is a rare, poorly characterized disorder associated with the clinical triad of visual loss caused by branch retinal artery occlusions, sensorineural hearing loss, and subacute encephalopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. The presence of hyperintense lesions in the corpus callosum on T2-weighted MR images may be a clue to the diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/51,52\">",
"       51,52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CADASIL &mdash; CADASIL is the acronym for",
"      <strong>",
"       c",
"      </strong>",
"      erebral",
"      <strong>",
"       a",
"      </strong>",
"      utosomal",
"      <strong>",
"       d",
"      </strong>",
"      ominant",
"      <strong>",
"       a",
"      </strong>",
"      rteriopathy with",
"      <strong>",
"       s",
"      </strong>",
"      ubcortical",
"      <strong>",
"       i",
"      </strong>",
"      nfarcts and",
"      <strong>",
"       l",
"      </strong>",
"      eukoencephalopathy. This disorder is a heritable, noninflammatory vasculopathy resulting from mutations in the gene for the protein Notch 3.",
"      <br/>",
"      <br/>",
"      The simplest way of diagnosing CADASIL and distinguishing it from PACNS is via a skin biopsy of clinically normal skin. The demonstration of granular osmiophilic material within the vascular basal lamina of arteries, arterioles, and precapillaries is diagnostic of CADASIL. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11530?source=see_link\">",
"       \"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome (MELAS) is a mitochondrial genetic disorder caused by a point mutation at nucleotide 3243 (A3243G), leading to stroke-like episodes before age 40, seizures, dementia, and ragged-red fibers in muscle [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=see_link&amp;anchor=H10#H10\">",
"       \"Mitochondrial myopathies: Clinical features and diagnosis\", section on 'MELAS'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cerebroretinal vasculopathy syndrome is an autosomal dominant retinal vasculopathy with cerebral leukodystrophy leading to stroke and dementias with middle-age onset [",
"      <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other conditions include amyloid angiopathy and inflammatory bowel diseases-associated cerebral vasculitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37001?source=see_link\">",
"       \"Cerebral amyloid angiopathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary angiitis of the central nervous system (PACNS) is a rare disease. The work-up and consideration of treatment for patients who may have PACNS must proceed simultaneously with plans for the systematic evaluation and exclusion of other disorders. If PACNS remains a diagnostic possibility after thinking through the list of potential alternative diagnoses, the performance of cerebral angiography",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biopsy of the leptomeninges and brain should be considered.",
"   </p>",
"   <p>",
"    In some cases, angiography or MR has already been performed and the possibility of PACNS is raised by the radiologist on the basis of nonspecific findings. In many such cases, the clinical suspicion for PACNS is low. The evaluation should be thorough, to exclude the mimics of PACNS, given the low specificity of the cerebral angiogram. While the findings of multiple ectasia and stenosis referred to as \"beading\" are characteristic of cerebral arteritis, these findings are not specific, and are commonly encountered in non vasculitic disorders such as atherosclerosis, infection, and vasospasm [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The specificity of cerebral angiography in the diagnosis of PACNS has been found to be as low as 30 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/55\">",
"     55",
"    </a>",
"    ]. The sensitivity and specificity of cerebral angiography for the diagnosis of primary angiitis of the central nervous system was examined in a study of 38 patients with possible PACNS who had undergone cerebral angiography, followed by cortical and leptomeningeal biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/30\">",
"     30",
"    </a>",
"    ]. Typical angiographic findings of vasculitis were seen in 14 patients, but none had primary angiitis of the CNS at brain biopsy. These observations emphasize the importance of the angiographic findings in the diagnosis of PACNS, and the need to evaluate those results together with the clinical and pathologic findings [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Selecting patients for angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of PACNS is most often suspected when a patient presents with a combination of neurologic findings. This may include decreased cognition or other alteration in mental status (particularly when associated with focal neurologic signs), headache, seizure, stroke,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cerebral hemorrhage in the absence of another more common explanation. The clinical scenario of multiple unexplained neurologic deficits with a chronic duration is more suggestive of GACNS, and cerebral angiography may not be sensitive in detecting the abnormalities in the small cerebral arteries.",
"   </p>",
"   <p>",
"    The sensitivity of cerebral angiography was illustrated by a literature review of 40 cases of GACNS not associated with Hodgkin disease, herpes zoster, sarcoidosis, or another identifiable cause, and including only those patients who had been evaluated with angiography or other neuroimaging techniques before death or biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/29\">",
"     29",
"    </a>",
"    ]. This study found that 56 percent of angiograms performed in patients with histologically proved GACNS were abnormal, but only 27 percent were diagnostic of vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/29\">",
"     29",
"    </a>",
"    ]. The low sensitivity of cerebral angiography resulted in part from the poor spatial resolution of the digital subtraction for defining small vessel disease, which is the primary vascular bed affected in GACNS.",
"   </p>",
"   <p>",
"    In the evaluation of patients for PACNS, we thus consider the angiographic findings in the context of the clinical presentation, the cerebral spinal fluid analysis and other imaging studies, and do not rely upon the angiography alone.",
"   </p>",
"   <p>",
"    Two small studies have suggested that the combination of a normal CSF and MR study has a high negative predictive value for PACNS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/1,36\">",
"     1,36",
"    </a>",
"    ]. These findings may raise the suspicion of RCVS. It is not uncommon to have normal MRI in the initial phase of RCVS, especially when patients present with headaches only [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Selecting patients for brain biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Brain biopsy is performed for two major reasons, which are to identify PACNS histologically and to identify other lesions or vasculitis mimics, particularly infection or malignancy. The sensitivity of brain biopsy for PACNS is approximately 75 percent, thus leaving the clinician with a false negative rate of 25 percent. Biopsies may identify a cause other than PACNS in up to 30 to 40 percent of patients. Two settings of particular concern are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of a focal lesion on MR with characteristics that suggest an inflammatory or infectious process, but noninvasive approaches to diagnosis have failed.",
"     </li>",
"     <li>",
"      The presence of a mass lesion in the brain for which the principal concern is usually malignancy or abscess. PACNS is occasionally a surprise finding. In such cases, the finding of vasculitis on pathologic exam does not exclude the diagnosis of infection or malignancy, and appropriate stains and markers should be pursued for accurate diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early reports of patients with PACNS suggested a dismal prognosis, with death following the diagnosis by a mean of only 45 days and a maximum survival of less than 10 months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/2\">",
"     2",
"    </a>",
"    ]. Immunosuppressive therapy has been associated with success in CNS vasculitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/56\">",
"     56",
"    </a>",
"    ]. However, no prospective studies of any of the therapies described below have been conducted in patients with PACNS.",
"   </p>",
"   <p>",
"    Thus, our suggestions for treatment are based upon anecdotal evidence related to PACNS and extrapolation of therapeutic strategies from other forms of vasculitis. The suggested approach for the treatment of PACNS is similar to the therapy of severe polyarteritis nodosa. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment and prognosis of polyarteritis nodosa\", section on 'Moderate and severe PAN'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Initial therapy of suspected PACNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the initial clinical evaluation has excluded infection with a reasonable degree of confidence and PACNS remains a diagnostic possibility, empiric therapy with glucocorticoids may be appropriate while the full work-up is completed.",
"   </p>",
"   <p>",
"    There have been no controlled trials in selecting the route of glucocorticoids in the management of the acute phase of PACNS. Some experts suggest avoiding intravenous pulse glucocorticoids, since this regimen is more likely to cloud the clinical picture by contributing to steroid-induced mental status changes, and suggest beginning the patient on the equivalent of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (to a maximum of 80",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    or its equivalent) until the diagnostic evaluation is complete.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Treatment of PACNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsy-confirmed cases with a picture of granulomatous inflammation on pathology, typical of GACNS, should be treated with a combination of glucocorticoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    . Other PACNS cases that are confirmed by biopsy but with lymphocytic inflammation rather than granulomatous pathology, referred to as atypical PACNS, should have an individualized therapeutic plan.",
"   </p>",
"   <p>",
"    Included in the atypical PACNS category are patients in whom the diagnosis is performed by cerebral angiogram and MRI findings, but not confirmed by biopsy where the mimics have been excluded. The CSF analysis in these patients is usually abnormal, excluding the diagnosis of RCVS. These patients should undergo a thorough evaluation of an infectious cause of their syndrome.",
"   </p>",
"   <p>",
"    The treatment of atypical PACNS should be tailored according to the severity and the extent of the neurologic involvement. Atypical PACNS patients should be treated initially with a high dose of glucocorticoids, then tapered slowly. The decision of adding",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    to the treatment regimen should be individualized according to the extent and the gravity of the neurologic deficits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;High-dose glucocorticoids are required to achieve disease control in PACNS. We initiate therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    at a dose of 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day to a maximum of 80",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    or its equivalent.",
"   </p>",
"   <p>",
"    Some experts begin with intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    , 15",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    each day for three days [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/57\">",
"     57",
"    </a>",
"    ]. Daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is begun on day four.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Either daily oral or intermittent (usually monthly) intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is reasonable as part of a remission induction strategy in PACNS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/58\">",
"     58",
"    </a>",
"    ]. Some clinicians prefer oral cyclophosphamide because of the ability to titrate the dose on a daily basis if necessary, thereby decreasing the likelihood of severe leukopenia. Other clinicians are more familiar with the intermittent administration of cyclophosphamide.",
"   </p>",
"   <p>",
"    Oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is begun at a dose of 1.5 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. In this setting, the white blood cell count (WBC) must be closely monitored and the cyclophosphamide dose adjusted to avoid severe leukopenia. The WBC count should remain above",
"    <span class=\"nowrap\">",
"     3500/microL.",
"    </span>",
"    The duration of the cyclophosphamide therapy is generally between three and six months, depending on when remission occurs and if there are any potential side effects that preclude the use of cyclophosphamide. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=see_link&amp;anchor=H24#H24\">",
"     \"General principles of the use of cyclophosphamide in rheumatic and renal disease\", section on 'Monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The typical regimen for intravenous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is 600 to 750",
"    <span class=\"nowrap\">",
"     mg/m2,",
"    </span>",
"    infused once a month, generally for between three and six months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/50/25386/abstract/57\">",
"     57",
"    </a>",
"    ]. A reduction in cyclophosphamide dose is necessary if there is significant renal insufficiency with not more than 500",
"    <span class=\"nowrap\">",
"     mg/m2",
"    </span>",
"    for patients with an estimated glomerular filtration rate less than 20",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Prophylactic therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The toxicities of PACNS treatments require the use of several prophylactic therapies to prevent bone loss and opportunistic infections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Osteoporosis prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients treated with high-dose glucocorticoids are at risk for glucocorticoid-induced osteoporosis. The prevention and treatment of glucocorticoid-induced osteoporosis are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=see_link\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Opportunistic infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    therapy are associated with an increased risk for opportunistic infection. Pneumocystis carinii, a common pathogen in immunosuppressed hosts, may cause lethal infections.",
"   </p>",
"   <p>",
"    In patients treated with the combination of high-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and another immunosuppressive agent, we recommend prophylaxis against Pneumocystis. Options for prophylactic regimens are discussed separately. The optimal duration of Pneumocystis prophylaxis after immunosuppressive therapy is tapered has not been defined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/4/9289?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients\", section on 'Prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    is associated with many potential treatment-related morbidities. Prophylactic approaches to these complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=see_link\">",
"     \"General principles of the use of cyclophosphamide in rheumatic and renal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Monitoring treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The response to treatment is monitored by periodic reassessment of symptoms, neurologic findings, and neuroimaging abnormalities. It is very important to differentiate between disease damage and disease progression. Neurologic deficits due to cerebral or cerebellar infarction may resolve slowly or not at all. Thus, for some patients, a response to treatment may only be indicated by symptomatic improvement (eg, resolution of headache), but not the resolution of MR lesions. A lack of new lesions on MRI is a more reliable way to assess for progression of the disease.",
"   </p>",
"   <p>",
"    With respect to neuroimaging, noninvasive studies are preferred to repeated angiography. A follow-up MR should be obtained four to six weeks after beginning treatment, then every three to six months throughout therapy, and subsequently according to the evolution of the disease.",
"   </p>",
"   <p>",
"    During the use of immunosuppressive treatment, patients require close clinical follow-up and laboratory monitoring in order to avoid preventable adverse effects of therapy. As an example, patients on daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    should have complete blood counts checked every two weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=see_link&amp;anchor=H24#H24\">",
"     \"General principles of the use of cyclophosphamide in rheumatic and renal disease\", section on 'Monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Duration of therapy and management of recurrent disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data available that address the optimal duration of therapy or the treatment of disease recurrence. The following approaches are based on the authors' experience and extrapolation from the treatment of other forms of vasculitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h3\">",
"     Glucocorticoid taper",
"    </span>",
"    &nbsp;&mdash;&nbsp;After four to six weeks at the initial dose,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    tapering should begin. There is no standard tapering regimen for PACNS, but regimens similar to the one outlined below are appropriate. Assuming that a patient begins prednisone treatment at 60",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    and remains on this dose for six weeks, the following taper will require a total of 26 weeks to reach a daily dose of 5 mg:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose should be tapered by 10 mg each week until a dose of 40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      is reached.",
"     </li>",
"     <li>",
"      After one week on 40 mg per day, the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose should be tapered by 5 mg each week until the patient reaches 20",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"     <li>",
"      After one week on 20",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose should be tapered by 2.5 mg each week until the patient reaches 10",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"     <li>",
"      After one week on 10",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose should be tapered by 1 mg every two weeks until the patient reaches 5",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"     <li>",
"      After two weeks on 5",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      the daily",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose should be tapered by 1 mg each month until the taper has been completed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Deviations from this regimen may be necessary if patients develop a significant complication of glucocorticoid therapy or experience disease recurrence. If a flare in symptoms occurs while the glucocorticoid dose is being lowered, the dose should be increased to the lowest amount that previously suppressed the clinical manifestations. Once the patient improves to the level of their prior status or stabilizes, reductions in the dose can be tried again.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h3\">",
"     Discontinuing cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three to six months of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    is sufficient for many patients. At this time, cyclophosphamide should be discontinued after approximately six months and replaced with a less toxic medication for an additional six to twelve months of maintenance therapy.",
"   </p>",
"   <p>",
"    By analogy with results in ANCA-associated systemic vasculitis, some clinicians switch from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg)",
"    </span>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     Methotrexate",
"    </a>",
"    can also be used, but may be limited by its difficulty to cross the blood brain barrier. Data on the duration of the maintenance therapy is not available, and the decision on the duration of the therapy should be individualized, based upon the response to therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6521?source=see_link\">",
"     \"Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary angiitis of the central nervous system (PACNS) is a vasculitis confined to the CNS that affects small- and medium-sized cerebral blood vessels. PACNS is not associated with any systemic involvement.",
"     </li>",
"     <li>",
"      PACNS that is confirmed by biopsy, but with lymphocytic inflammation rather than granulomatous pathology, is referred to as atypical PACNS. Included in the atypical PACNS category are patients in whom the diagnosis is made by cerebral angiography and magnetic resonance imaging (MRI) findings, but not confirmed by biopsy, and where vasculitis mimics have been excluded. The cerebral spinal fluid (CSF) analysis in these patients is usually abnormal, excluding diagnosis of a reversible cerebral vasoconstriction syndrome (RCVS) or other vasculitis mimics. This classification is based upon the authors&rsquo; clinical experience and is accepted by many specialists. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathology'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      A thorough evaluation should be performed on the CSF and the pathology of patients with atypical PACNS to exclude any infectious or malignant process.",
"     </li>",
"     <li>",
"      Clinical manifestations of PACNS include one or more of the following: encephalopathy, seizures, stroke, headache, personality change, weakness, cranial neuropathy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      altered level of consciousness. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory testing and serological assays are used primarily to exclude other etiologies of CNS dysfunction. Abnormal laboratory features compatible with PACNS include elevated CSF protein and a CSF pleocytosis. None of these findings is specific for PACNS. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Laboratory findings'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Serologic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The combination of normal CSF findings and a normal MRI has a high negative predictive value for the diagnosis of PACNS . (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Selecting patients for angiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cerebral angiography findings that are compatible with (but not diagnostic of) PACNS include beading, circumferential or eccentric luminal narrowing, occlusions of one or more arteries,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an avascular mass effect. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Angiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In performing angiography for the evaluation of potential PACNS, it is essential to bear in mind two points:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The sensitivity of angiography is only about 60 percent. Thus, a negative angiogram cannot be used to exclude the diagnosis of PACNS.",
"     </li>",
"     <li>",
"      The specificity of the cerebral angiogram can be as low as 30 percent. No single angiographic feature or combination of features is diagnostic of PACNS. A positive angiogram is not diagnostic of PACNS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The gold standard for the diagnosis of PACNS is histopathology. Sampling of the leptomeninges as well as the underlying cortex increases the diagnostic yield. However, because of sampling error,",
"      <span class=\"nowrap\">",
"       brain/leptomeningeal",
"      </span>",
"      biopsies are only about 75 percent sensitive for the diagnosis of PACNS. The finding of vasculitis on brain tissue does not exclude an associated infection or lymphoproliferative disorder. Appropriate stains, viral studies, and immunophenotyping should be performed on the biopsy to exclude the diagnosis of infection or malignancy. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Brain and leptomeningeal biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PACNS has a host of potential clinical and radiologic mimickers, the most common of which are the reversible cerebral vasoconstriction syndromes. In patients in whom the diagnosis of PACNS is suspected, an alternative diagnosis is more likely to be correct. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RCVS are major mimics of PACNS. RCVS comprise a group of disorders characterized by reversible cerebral vasoconstriction, acute onset of thunderclap headaches with or without neurologic deficit, and normal findings on CSF analysis. It can be associated with postpartum state, sympathomimetic agents, and use of selective serotonin reuptake inhibitors. The cerebral vascular studies demonstrate typical areas of beading in multiple vessel beds that are usually reversible in follow-up studies. The suggested pathophysiology of RCVS is that of vasospasm, since the pathologic findings do not indicate any vasculitic pattern.",
"     </li>",
"     <li>",
"      We suggest treating GANCS with a combination of glucocorticoids and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      &nbsp;(",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Treatment of atypical PACNS should be individualized according to the severity and the extent of the neurologic deficit. (See",
"      <a class=\"local\" href=\"#H32\">",
"       'Treatment of PACNS'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend the use of measures to prevent osteoporosis and Pneumocystis infections during the treatment of PACNS (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Prophylactic therapies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/1\">",
"      Calabrese LH, Duna GF, Lie JT. Vasculitis in the central nervous system. Arthritis Rheum 1997; 40:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/2\">",
"      Sigal LH. The neurologic presentation of vasculitic and rheumatologic syndromes. A review. Medicine (Baltimore) 1987; 66:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/3\">",
"      Younger DS. Vasculitis of the nervous system. Curr Opin Neurol 2004; 17:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/4\">",
"      Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988; 67:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/5\">",
"      Lie JT. Primary (granulomatous) angiitis of the central nervous system: a clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol 1992; 23:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/6\">",
"      Kattah JC, Cupps TR, Di Chiro G, Manz HJ. An unusual case of central nervous system vasculitis. J Neurol 1987; 234:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/7\">",
"      Calabrese LH, Gragg LA, Furlan AJ. Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol 1993; 20:2046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/8\">",
"      Lie JT. Classification and histopathologic spectrum of central nervous system vasculitis. Neurol Clin 1997; 15:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/9\">",
"      Thomas L, Davidson M, McCluskey RT. Studies of PPLO infection. I. The production of cerebral polyarteritis by Mycoplasma gallisepticum in turkeys; the neurotoxic property of the Mycoplasma. J Exp Med 1966; 123:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/10\">",
"      Alexander JJ, Lasky AS, Graf WD. Stroke associated with central nervous system vasculitis after West Nile virus infection. J Child Neurol 2006; 21:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/11\">",
"      Outteryck O, S&eacute;n&eacute;chal O, Berteloot D, et al. [Cerebral vasculitis secondary to Varicella-Zoster virus infection]. Rev Neurol (Paris) 2005; 161:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/12\">",
"      Bhat G, Mathur DS, Saxena GN, et al. Granulomatous angiitis of the central nervous system associated with herpes zoster. J Assoc Physicians India 2002; 50:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/13\">",
"      Brannagan TH 3rd. Retroviral-associated vasculitis of the nervous system. Neurol Clin 1997; 15:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/14\">",
"      Nogueras C, Sala M, Sasal M, et al. Recurrent stroke as a manifestation of primary angiitis of the central nervous system in a patient infected with human immunodeficiency virus. Arch Neurol 2002; 59:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/15\">",
"      Kossorotoff M, Touz&eacute; E, Godon-Hardy S, et al. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology 2006; 66:1121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/16\">",
"      van der Ven AJ, van Oostenbrugge RJ, Kubat B, Tervaert JW. Cerebral vasculitis after initiation antiretroviral therapy. AIDS 2002; 16:2362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/17\">",
"      Alhalabi M, Moore PM. Serial angiography in isolated angiitis of the central nervous system. Neurology 1994; 44:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/18\">",
"      Scolding NJ, Joseph F, Kirby PA, et al. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 2005; 128:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/19\">",
"      Hashizume Y, Yoshida M, Suzuki E, Hirayama M. A 65-year-old man with headaches and left homonymous hemianopsia. Neuropathology 2004; 24:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/20\">",
"      Harkness KA, Coles A, Pohl U, et al. Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy. Eur J Neurol 2004; 11:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/21\">",
"      Tamargo RJ, Connolly ES Jr, McKhann GM, et al. Clinicopathological review: primary angiitis of the central nervous system in association with cerebral amyloid angiopathy. Neurosurgery 2003; 53:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/22\">",
"      Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-2000. A 63-year-old man with changes in behavior and ataxia. N Engl J Med 2000; 342:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/23\">",
"      Salvarani C, Brown RD Jr, Calamia KT, et al. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. Rheumatology (Oxford) 2008; 47:1671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/24\">",
"      Fountain NB, Eberhard DA. Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature. Neurology 1996; 46:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/25\">",
"      Salvarani C, Brown RD Jr, Calamia KT, et al. Primary CNS vasculitis with spinal cord involvement. Neurology 2008; 70:2394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/26\">",
"      Hajj-Ali RA, Singhal AB, Calabrese LH. Reversible cerebral vasoconstrictive syndrome (abstract). Arthritis Rheum 2008; 58(Suppl 9).",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/27\">",
"      Hellmann DB, Roubenoff R, Healy RA, Wang H. Central nervous system angiography: safety and predictors of a positive result in 125 consecutive patients evaluated for possible vasculitis. J Rheumatol 1992; 19:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/28\">",
"      Calabrese LH, Furlan AJ, Gragg LA, Ropos TJ. Primary angiitis of the central nervous system: diagnostic criteria and clinical approach. Cleve Clin J Med 1992; 59:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/29\">",
"      Vollmer TL, Guarnaccia J, Harrington W, et al. Idiopathic granulomatous angiitis of the central nervous system. Diagnostic challenges. Arch Neurol 1993; 50:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/30\">",
"      Kadkhodayan Y, Alreshaid A, Moran CJ, et al. Primary angiitis of the central nervous system at conventional angiography. Radiology 2004; 233:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/31\">",
"      Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/32\">",
"      Pomper MG, Miller TJ, Stone JH, et al. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 1999; 20:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/33\">",
"      Molloy ES, Singhal AB, Calabrese LH. Tumour-like mass lesion: an under-recognised presentation of primary angiitis of the central nervous system. Ann Rheum Dis 2008; 67:1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/34\">",
"      Appenzeller S, Faria AV, Zanardi VA, et al. Vascular involvement of the central nervous system and systemic diseases: etiologies and MRI findings. Rheumatol Int 2008; 28:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/35\">",
"      Bekiesiska-Figatowska M. T2-hyperintense foci on brain MR imaging. Med Sci Monit 2004; 10 Suppl 3:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/36\">",
"      Stone JH, Pomper MG, Roubenoff R, et al. Sensitivities of noninvasive tests for central nervous system vasculitis: a comparison of lumbar puncture, computed tomography, and magnetic resonance imaging. J Rheumatol 1994; 21:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/37\">",
"      Greenan TJ, Grossman RI, Goldberg HI. Cerebral vasculitis: MR imaging and angiographic correlation. Radiology 1992; 182:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/38\">",
"      Cloft HJ, Phillips CD, Dix JE, et al. Correlation of angiography and MR imaging in cerebral vasculitis. Acta Radiol 1999; 40:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/39\">",
"      Parisi JE, Moore PM. The role of biopsy in vasculitis of the central nervous system. Semin Neurol 1994; 14:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/40\">",
"      Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium. Arthritis Rheum 1996; 39:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/41\">",
"      Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. Semin Arthritis Rheum 1979; 8:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/42\">",
"      Hanly JG, Walsh NM, Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol 1992; 19:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/43\">",
"      Lyons MK, Caselli RJ, Parisi JE. Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases. J Neurosurg 2008; 108:1024.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/44\">",
"      Barinagarrementeria F, Cant&uacute; C. Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study. Stroke 1998; 29:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/45\">",
"      Horowitz DR, Tuhrim S, Budd J, Goldman ME. Aortic plaque in patients with brain ischemia: diagnosis by transesophageal echocardiography. Neurology 1992; 42:1602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/46\">",
"      Lie JT. Malignant angioendotheliomatosis (intravascular lymphomatosis) clinically simulating primary angiitis of the central nervous system. Arthritis Rheum 1992; 35:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/47\">",
"      Demirer T, Dail DH, Aboulafia DM. Four varied cases of intravascular lymphomatosis and a literature review. Cancer 1994; 73:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/48\">",
"      Nakahara T, Saito T, Muroi A, et al. Intravascular lymphomatosis presenting as an ascending cauda equina: conus medullaris syndrome: remission after biweekly CHOP therapy. J Neurol Neurosurg Psychiatry 1999; 67:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/49\">",
"      Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology 1979; 29:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/50\">",
"      Kleffner I, Deppe M, Mohammadi S, et al. Diffusion tensor imaging demonstrates fiber impairment in Susac syndrome. Neurology 2008; 70:1867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/51\">",
"      Do TH, Fisch C, Evoy F. Susac syndrome: report of four cases and review of the literature. AJNR Am J Neuroradiol 2004; 25:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/52\">",
"      Susac JO, Murtagh FR, Egan RA, et al. MRI findings in Susac's syndrome. Neurology 2003; 61:1783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/53\">",
"      Dimauro S, Hirano M. Pedaling from genotype to phenotype. Arch Neurol 2006; 63:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/54\">",
"      Richards A, van den Maagdenberg AM, Jen JC, et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 2007; 39:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/55\">",
"      Duna GF, Calabrese LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 1995; 22:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/56\">",
"      Kissel JT, Rammohan KW. Pathogenesis and therapy of nervous system vasculitis. Clin Neuropharmacol 1991; 14:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/57\">",
"      Guillevin L, Pagnoux C. When should immunosuppressants be prescribed to treat systemic vasculitides? Intern Med 2003; 42:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/50/25386/abstract/58\">",
"      Gayraud M, Guillevin L, Cohen P, et al. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br J Rheumatol 1997; 36:1290.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8230 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-1745D172DA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25386=[""].join("\n");
var outline_f24_50_25386=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H43\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Amyloid angiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Serologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Angiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Repeat angiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - MR imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - MR angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Brain and leptomeningeal biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Reversible cerebral vasoconstriction syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Systemic vasculitis involving the brain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Connective tissue diseases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Cerebral emboli",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Intravascular lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Miscellaneous",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Selecting patients for angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Selecting patients for brain biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Initial therapy of suspected PACNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Treatment of PACNS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Prophylactic therapies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Osteoporosis prevention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Opportunistic infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Monitoring treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Duration of therapy and management of recurrent disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      - Glucocorticoid taper",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      - Discontinuing cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8230\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8230|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/62/11234\" title=\"diagnostic image 1\">",
"      Carotid artery angiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?37/8/38017\" title=\"diagnostic image 2\">",
"      Angiogram RCVS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8230|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/58/16292\" title=\"picture 1\">",
"      Carotid angiograms in ICNSV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/10/41128?source=related_link\">",
"      Approach to HIV-infected patients with central nervous system lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/2/28713?source=related_link\">",
"      Central nervous system tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/8/37001?source=related_link\">",
"      Cerebral amyloid angiopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/16/11530?source=related_link\">",
"      Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24458?source=related_link\">",
"      Cerebrovascular disorders complicating pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40616?source=related_link\">",
"      Classification and incidence of childhood vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/18/298?source=related_link\">",
"      Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/36/28232?source=related_link\">",
"      Clinical manifestations and diagnosis of cysticercosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/26/9641?source=related_link\">",
"      Clinical manifestations and diagnosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=related_link\">",
"      Clinical manifestations and diagnosis of rheumatoid vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35225?source=related_link\">",
"      Clinical manifestations of Lyme disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43401?source=related_link\">",
"      Clinical manifestations of mixed connective tissue disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/31/23034?source=related_link\">",
"      Clinical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23786?source=related_link\">",
"      Clinical presentation and diagnosis of pheochromocytoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/10/40105?source=related_link\">",
"      Cryptogenic stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/43/5816?source=related_link\">",
"      Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/42/32426?source=related_link\">",
"      Disorders affecting the spinal cord",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/15/31994?source=related_link\">",
"      Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8182?source=related_link\">",
"      Epidemiology and clinical manifestations of Bartonella infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21383?source=related_link\">",
"      Epidemiology, pathogenesis, and pathology of Churg-Strauss syndrome (allergic granulomatosis and angiitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/40/16008?source=related_link\">",
"      General principles of the use of cyclophosphamide in rheumatic and renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32953?source=related_link\">",
"      Headache, migraine, and stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/12/13511?source=related_link\">",
"      Intravascular large cell lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6521?source=related_link\">",
"      Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7370?source=related_link\">",
"      Mitochondrial myopathies: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/8/20616?source=related_link\">",
"      Neurologic sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/44/26312?source=related_link\">",
"      Neurosyphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/63/22522?source=related_link\">",
"      Overview of cryoglobulins and cryoglobulinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/13/38104?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=related_link\">",
"      Prevention and treatment of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/50/21288?source=related_link\">",
"      Stroke caused by varicella zoster virus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/19/12601?source=related_link\">",
"      Thunderclap headache",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/4/9289?source=related_link\">",
"      Treatment and prevention of Pneumocystis pneumonia in non-HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=related_link\">",
"      Treatment and prognosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_50_25387="Metabolic causes hydrops";
var content_f24_50_25387=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Metabolic causes of hydrops",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        MPS VII (Sly Disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        MPS IVA (Morquio type A)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucolipidosis I (Sialidosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucolipidosis II (I-Cell Disease)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gaucher Disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Niemann-Pick C",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Farber Disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GM1 Gangliosidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sialic Acid Storage Disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary Carnitine Deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fumarase Deficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory Chain Disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congenital Disorders of Glycosylation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Neonatal Haemochromatosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zellweger",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GSD IV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Deficiencies of Red Cell Glycolytic/Pentose Phosphate Pathway Enzymes (eg, G6PDH Deficiency, Pyruvate Kinase Deficiency)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of V Reid Sutton, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25387=[""].join("\n");
var outline_f24_50_25387=null;
var title_f24_50_25388="Causes of anemia in HIV";
var content_f24_50_25388=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F65608&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F65608&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of anemia in HIV-infected patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       Anemia of chronic disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Sepsis/bacteremia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Bone marrow infiltration",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Disseminated fungal infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       Histoplasmosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       Penicillium marneffei",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       Pneumocystis jiroveci",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Disseminated mycobacterial infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       Mycobacterium tuberculosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       Mycobacterium avium intracellulare complex",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist3\">",
"       Other non-tuberculous mycobacteria",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Visceral leishmaniasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Viral infections",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Parvovirus B19",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Cytomegalovirus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Epstein Barr virus (EBV)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist2\">",
"       Human immunodeficiency virus (HIV)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Malignancy/bone marrow involvement",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Non-Hodgkin lymphoma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Hodgkin lymphoma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Castleman's disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Kaposi's sarcoma (rare)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Autoimmune hemolytic anemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypersplenism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Megaloblastic anemia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Vitamin B12 or folate deficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Iron deficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Bleeding",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       Gastrointestinal blood loss",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Medications",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thrombotic thrombocytopenic purpura",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Disseminated intravascular coagulation",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25388=[""].join("\n");
var outline_f24_50_25388=null;
var title_f24_50_25389="Pravastatin hospitalization";
var content_f24_50_25389=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pravastatin reduces hospitalization for cardiovascular causes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 282px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The Kaplan-Meier plots of time to first hospitalization show that therapy with pravastatin signifiantly reduces the number of hospitalizations for cardiovascular diagnoses compared to placebo (p = 0.0007).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from West of Scotland Coronary Prevention Study Group, J Am Coll Cardiol 1999; 33:909.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25389=[""].join("\n");
var outline_f24_50_25389=null;
var title_f24_50_25390="ConventionaL vs impedance";
var content_f24_50_25390=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68998&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    (A) conventional pH catheter (diameter 2.1 mm) used to monitor gastroesophageal reflux and intragastric pH, (B) multi-channel intraluminal impedance-pH catheter (diameter 2.1 mm) with impedance electrodes (4 mm in length) set in pairs at 2-cm intervals",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 400px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This allows for six impedance rings and one pH electrode in the esophagus and a second pH electrode in the stomach. The pH sensor is placed 5 cm above the LES and gastric pH at 10 cm below the LES.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Radu Tutuian, MD and Donald O Castell, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25390=[""].join("\n");
var outline_f24_50_25390=null;
var title_f24_50_25391="CDC algorithm for prenatal GBS screening";
var content_f24_50_25391=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Algorithm for recommended laboratory testing for prenatal screening for group B streptococcal (GBS) colonization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 544px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Direct plating with appropriate media may be done in addition to enriched culture. Direct plating should not be used as the sole means to identify GBS.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_50_25391=[""].join("\n");
var outline_f24_50_25391=null;
